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1.1. Definition of sleeve resection 
Primary carcinoma of the lung was a rare neoplasm in our civilization at the 
turn of this century but now ranks fírst among malignant neoplasms in men 
and women alike. In 1986, death by carcinoma of the lung surpassed death 
by carcinoma of the breast in women (Sabiston, 1990). However, attempts 
to control cigarette smoking in the United States are becoming successful. 
The incidence of lung cancer in the United States has recently declined and 
a decrease in the overall lung cancer mortality rate in men is expected by 
the early 1990s (Garfinkel et al., 1990). Unfortunately, in the Netherlands 
the situation is different. According to a recent survey, in 1990 the number 
of smokers has increased by 2% in comparison to 1989 (Stichting 
Volksgezondheid en Roken, 1991). 
Except for small cell lung carcinoma, surgical extirpation is the primary 
basis of treatment. In the 1930s and 1940s pneumonectomy was the only 
accepted surgical procedure for bronchogenic carcinoma. Lobectomy was 
initially only considered reasonable when there was evidence of diminished 
pulmonary or cardiac reserve. Later, it was shown that it may afford similar 
survival rates as pneumonectomy if the lesion could be totally excised by 
lobectomy (Crabbe et al., 1989). 
At the present time, lobectomy and pneumonectomy are considered the 
standard surgical procedures for bronchogenic carcinoma. Sleeve resection 
is a procedure in which a segment of a bronchus is removed, generally in 
continuity with a diseased lobe. It was initially introduced as a compromise 
operation for patients with a centrally located lung cancer who could not 
tolerate pneumonectomy because of insufficient pulmonary reserve and 
for whom lobectomy was an inadequate cancer operation. Afterwards, it 
was shown that sleeve resection is an effective lung cancer operation with 
long-term results comparable to pneumonectomy (Faber, 1987). 
What exactly is meant by sleeve resection ? In the Oxford dictionary 
(Sykes, 1984) a sleeve is defined as part of a garment that covers the arm, 
a wind-sock or a tube enclosing a rod or a smaller tube. 
In thoracic surgery, sleeve resection refers to removal of a circumferential 
part of bronchus or trachea in order to completely remove a benign or 
malignant lesion. In a lobectomy of the right upper lobe with sleeve 
resection of the main bronchus, the right upper lobe is removed together 
with a circumferential part of the main bronchus. An end-to-end anastomosis 
of the intermediate bronchus to the main bronchus is performed (fig 1.1). 
2 
Figure 1.1 Righi upper sleeve lobectomy. (From Lowe JE, Bridgman AH, Sabiston 
DC. The role of bronchoplastic procedures in the surgical management of 
benign and malignant pulmonary lesions.JThorac Cardiovasc Surg 1982; 
83:227-234. Used by permission of The C.V. Mosby Company.) 
This is also referred to as sleeve lobectomy of the right upper lobe and is 
a full sleeve resection, meaning that a complete annular, circumferential 
part of the bronchus is removed. In a partial sleeve resection, better called 
a bronchial wedge excision, a part of the bronchus is removed without 
complete interruption of bronchial integrity, whereafter the remaining 
defect is closed (fig 1.2). In this situation part of the bronchus, and thus the 
bronchial circulation, is preserved in contrary to a full sleeve resection. 
Figure 12 Wedge or partial sleeve resection of the left main bronchus. (From Lowe 
JE, Bridgman AH, Sabiston DC. The role of bronchoplastic procedures in 
the surgical management of benign and malignant pulmonary lesions. 
J Thorac Cardiovasc Surg 1982; 83:227-234. Used by permission of The 
C.V. Mosby Company.) 
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Sleeve resections can be applied to any lobe or segment of a lobe or even 
an entire lung. In this last procedure, a circumferential part of the trachea 
is removed with anastomosis of the remaining main bronchus in the 
trachea. This is called a sleeve pneumonectomy, mostly performed on the 
right side. 
Sleeve resection of a main bronchus is also possible without excision of 
pulmonary parenchyma. This is usually performed on the left side as the 
left main bronchus is much longer than the right one. 
Sleeve and wedge resections of the bronchus are part of the bronchoplastic 
procedures. Bronchoplasty can be defined as "plastic surgery of the 
bronchus". It is a general term that includes all techniques in which a 
benign or malignant lesion is removed with a part of the bronchus. This 
defect is subsequently closed by approximating the divided bronchial ends 
or by rotating a flap of the remaining bronchial wall to fill up the defect. 
This last procedure is called a rotating bronchoplasty. 
In bronchoplastic procedures functional lung tissue is preserved which 
would otherwise be lost. This is of special importance in functionally 
compromised patients for which these operations were initially advocated. 
However, preservation of lung tissue, if possible, is important in any 
patient, not only for functional reasons but also to make a subsequent 
resection posssible, if this proves to be necessary. Indeed, a certain number 
of patients operated on for lung cancer will develop a second primary 
cancer, for which a second resection might be possible. In this way, 
bronchial sleeve resection, if feasible, can be considered the operation of 
choice, as the only surgical alternative in these patients is a pneumonectomy 
(Faber, 1987). 
1.2. Purpose and description of the present study 
In this study the results of full bronchial sleeve resection operations 
performed on lung tumors at the Antonius Hospital, Utrecht and Nieuwegein, 
the Netherlands, are presented. This includes sleeve lobectomy and sleeve 
resection of a main bronchus, in which a circumferential part of the 
bronchus is removed followed by an end-to-end anastomosis. Operative 
mortality, complications and long-term results are reported in detail. 
Special attention is given to long-term survival according to the most 
recent TNM classification (Mountain, 1986). Complications particular to 
these bronchial anastomoses, not encountered in standard resectional 
procedures, are emphasized. 
The pathological classification of lung cancer is reviewed in chapter 2. 
Precise staging of lung cancer is of utmost importance since not only 
treatment and prognosis depend on it, but also the evaluation of long-term 
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results. The newer TNM classification of lung cancer is presented in 
chapter 3. 
Controversy surrounding the staging of the mediastinum is centered 
around the exact role of noninvasive versus invasive techniques. The 
question whether computed tomography can replace mediastinoscopy in 
the preoperative staging of bronchogenic carcinoma is examined in 
chapter 4. 
After some historical notes about sleeve resection (chapters), the indications, 
technique and complications of bronchial sleeve resection are discussed in 
chapter 6. 
In chapter 7, we look at the long-term results of bronchial sleeve resection 
performed for bronchogenic carcinoma, mostly squamous cell carcinoma. 
Long-term survival in relation to nodal involvement is presented in detail 
and possible implications are discussed. 
Chapter 8 is devoted to centrally located, typical bronchial carcinoid 
tumors, which are of low-grade malignancy. The indications and results of 
bronchial sleeve resection in this particular group are discussed. 
In chapter 9, patients are presented who developed a second primary cancer 
after bronchial sleeve resection. Possible treatment modalities and their 
specific results are given. 
After sleeve resection, in some patients a completion pneumonectomy will 
eventually be necessary, mostly related to complications of the bronchial 
anastomosis. The incidence, indications and results of completion 
pneumonectomy after bronchial sleeve resection are presented in 
chapter 10. 
Summary and conclusions are given in English, Dutch and French in 
chapter 11. 
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2.1. Morphological classification of lung tumors 
There are many classifications of lung tumors (Spencer, 1985) but the most 
widely accepted is that of the World Health Organization (WHO, 1981). It 
provides a detailed classification and comprises a spectrum of malignant 
tumors that differ morphologically and clinically but which have a common 
origin from the lower respiratory tract. This classification was slightly 
adapted by Melamed in 1987 for a more practical usage (table 2.1 ). A very 
important consideration is the differentiation between small cell and non-
small cell lung carcinoma as the treatment modalities are different for these 
two types, although the distinction can be rather difficult to make. In one 
series, differentiation by light microscopy proved to be difficult in 17% of 
carcinomas, the so-called grey area (Lamb, 1984). In these cases electron 
microscopy is useful to detect neuroendocrine granules which are typical 
for small cell carcinoma. 
Table 2.1. Histological typing of lung tumors (World Health 
Organization, 1981 ; modified by Melamed in 1987). 
1. Epidermoid carcinoma 
Variant : keratinizing squamous carcinoma 
2. Adenocarcinoma 
a. acinar adenocarcinoma 
b. papillary adenocarcinoma 
с solid carcinoma with mucin secretion 
d. bronchoalveolar carcinoma 
3. Small cell carcinoma 
a. oat cell carcinoma 
b. intermediate cell type 
4. Large cell (undifferentiated) carcinoma 
a. clear cell carcinoma 
b. giant cell carcinoma 
5. Adenosquamous carcinoma 
6. Carcinoid 
7. Salivary gland carcinoma 
a. adenoid cystic carcinoma 
b. mucoepidermoid carcinoma 
8. Pulmonary blastoma 
9. Sarcomas of various types, lymphomas, melanoma 
10. Mesothelioma 
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Most important histological types are : 
1. Epidermoid carcinoma (squamous cell carcinoma) 
In most series this is the most common type with an incidence from 40 to 
70% of total lesions. It is most frequently found in heavy smokers. 
Squamous cell carcinomas typically arise from major bronchi, usually the 
lobar or first segmental bronchus. They have a central localization and are 
locally invasive. With further growth they may give rise to bronchial 
obstruction and they frequently metastasize to hilar, mediastinal and 
supraclavicular lymph nodes. Brain and bone metastases are found less 
frequently than with adenocarcinoma. The keratinizing variety is considered 
the most slowly growing of the epidermoid cancers and the least likely to 
metastasize widely. 
Because of their central localization and their tendency to be locally 
invasive, sleeve resection is particularly suited for this type of tumors. 
In most series of sleeve resections including ours there is a preponderance 
of squamous cell carcinoma [see chapter 7]. 
2. Adenocarcinoma 
Adenocarcinomas arise from peripheral bronchioles. In some series 
(Melamed et al., 1987) it is the most common lung cancer. They give rise 
to regional lymph node metastases but also frequently to blood-bom 
distant metastases. A special subset is bronchoalveolar carcinoma which 
grows along alveolar septa and spreads troughout the lung by aerogenous 
dissemination. 
Because of their growth pattern and more peripheral localization sleeve 
resection is not often indicated in this type of lung tumors. 
3. Small cell lung carcinoma 
Small cell carcinomas comprise about 15% of all lung cancers. These are 
the most aggressive carcinomas of the lung which often present with 
distant metastases. They are subdivided into oat cell and intermediate cell 
types. Because of their common origin they are grouped together with the 
typical and atypical carcinoid tumors as Kulchitsky's cell carcinomas, of 
which small cell carcinomas constitute type ΠΙ. This is explained in more 
detail in chapter 8. The primary form of treatment for small cell lung 
carcinoma is generally polychemotherapy, in selected cases followed by 
surgery for residual lesions. On the other hand, some consider surgery to 
be indicated in the early stages of the disease (Shepherd et al., 1991). 
4. Large cell undifferentiated carcinomas 
These are subdivided into solid, clear cell and giant cell variants, which are 
all carcinomas with an aggressive clinical behavior. 
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5. Carcinoid tumors 
These are rare tumors, representing 2-3% of all lung tumors. They are 
subdivided into typical and atypical variants which comprise type I and Π 
of Kulchitsky's cell carcinoma [see chapter 8]. Type I tumors are mostly 
centrally located and are particular amenable to bronchoplastic procedures, 
sometimes in combination with laser therapy. In our group of sleeve 
resections, carcinoid tumors were the second most common histologic 
type. 
Most clinicians and some pathologists fmd the WHO classification too 
extensive and use a more condensed version comprised of four categories: 
squamous cell carcinoma, adenocarcinoma, small cell undifferentiated 
carcinoma and large cell undifferentiated carcinoma (Lamb, 1984). Another 
useful classification with four categories is : squamous cell carcinoma, 
adenocarcinoma, undifferentiated or anaplastic carcinoma including small 
cell, large cell and oat-cell carcinoma, and bronchoalveolar carcinoma. 
Giant-cell carcinoma of the lung is considered by some as a separate entity 
because of its aggressive clinical behavior and bizarre pathological features 
(Razzuk et al., 1976). 
2.2. Characteristic lung tumors 
Pancoast tumors arise in the apex of the lung and hence are called superior 
sulcus tumors. They may infiltrate neighbouring structures in the upper 
mediastinum and involve the brachial plexus, subclavian artery and 
cervical sympathetic nerves. They may erode the upper first and second 
thoracic ribs. Pathologically, squamous cell carcinoma, adenocarcinoma 
or large cell carcinoma are most frequently found here (Hilaris et al., 1987). 
A peculiar entity is scar carcinoma of the lung which is found in scar tissue 
caused by trauma, pulmonary infarcts, pneumoconiosis, tuberculosis and 
other inflammatory lesions. One theory to explain the development of 
cancer in scars is blockage of the lymphatics by scar tissue, which may 
cause concentration of an anthracotic pigment that contains carcinogen in 
the area of the lesion and may ultimately produce a malignant change 
(Spencer, 1985). However, there is no definite proof of this condition 
because the scarring may be due to carcinoma of the lung from the 
beginning. 
In our series of 145 bronchial sleeve resections the most common histologic 
types were squamous cell carcinoma (80.0%) and carcinoid tumor (9.0%). 
The other histologic types were less often found and are listed in table 7.2. 
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3.1. Introduction 
Correct staging of lung cancer is of utmost importance. Survival after 
treatment for lung cancer is closely related to the precise tumor stage at the 
time of treatment. Staging is also important when comparing different 
forms of treatment and for reporting end results and survival data. 
The TNM classification is widely accepted as a staging system. It is 
composed of three distinct categories : "T" refers to the primary tumor, "N" 
represents regional lymph nodes and "M" distant metastases. The different 
TNM subsets are then grouped into a number of stages of disease. In 1986 
a new TNM classification for lung cancer was put forward (Mountain, 
1986; Goldstraw, 1989). 
3.2. TNM categories 
3.2.1. Τ category (primary tumor) 
Following levels are described : 
TX Tìimor proven by the presence of malignant cells in bronchopulmonary 
secretions but not visualized by roentgenography or bronchoscopy, or 
any tumor that cannot be assessed as in a retreatment staging. 
TO No evidence of primary tumor. 
TIS Carcinoma in situ. 
Tl A tumor that is 3.0 cm or less in greatest dimension, surrounded by 
lung or visceral pleura, and without evidence of invasion proximal to 
a lobar bronchus at bronchoscopy. 
T2 A tumor more than 3.0 cm in greatest dimension, or a tumor of any size 
that either invades the visceral pleura or has associated atelectasis or 
obstructive pneumonitis extending to the hilar region. At bronchoscopy, 
the proximal extent of demonstrable tumor must be within a lobar 
bronchus or at least 2.0 cm distal to the carina. Any associated 
atelectasis or obstructive pneumonitis must involve less than an entire 
lung. 
T3 A tumor of any size with direct extension into the chest wall (including 
superior sulcus tumors), diaphragm, or the mediastinal pleura or 
pericardium without involving the heart, great vessels, trachea, 
esophagus, or vertebral body, or a tumor in the main bronchus within 
2.0 cm of the carina without involving the carina. 
T4 A tumor of any size with invasion of the mediastinum or involving 
heart, great vessels, trachea, esophagus, vertebral body, or carina or 
with presence of malignant pleural effusion. 
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ТЗ and Т4 tumors are illustrated in fig 3.1 and 3.2. 
Figure 3.1 T3 tumor with direct extension into the (a) chest wall (b) including 
superior sulcus tumors. (From Mountain CF. A new international staging 
system f or lung cancer. Chest 1986; 89:225S-233S. Used by permission of 
The American College of Chest Physicians.) 
Figure 32 T4 tumor with superior vena cava syndrome. (From Mountain CF. A new 
international staging system for lung cancer. Chest 1986; 89:225S-233S. 
Used by permission of The American College of Chest Physicians.) 
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Following footnotes are added for Tl and T4 : 
Tl The uncommon superficial tumor of any size whose invasive 
component is limited to the bronchial wall and that may extend 
proximal to the main bronchus is classified as Tl. 
T4 Most pleural effusions associated with lung cancer are due to tumor. 
There are, however, some few patients in whom cytopathologic 
examination of pleural fluid (on more than one specimen) is negative 
for tumor and the fluid is nonbloody and is not an exudate. When these 
elements and clinical judgment dictate that the effusion is not related 
to the tumor, the cases should be staged Tl, T2 or T3, with effusion 
being excluded as a staging element. 
3.2.2. N category (node) 
Following regional lymph node descriptors exist : 
NO No demonstrable metastasis to regional lymph nodes. 
N1 Metastasis to lymph nodes in the peribronchial or the ipsilateral hilar 
region, or both, including direct extension. 
N2 Metastasis to ipsilateral mediastinal lymph nodes and subcarinal 
lymph nodes. 
N3 Metastasis to contralateral mediastinal lymph nodes, contralateral 
hilar lymph nodes, or ipsilateral or contralateral scalene or 
supraclavicular lymph nodes. 
N2 and N3 involvement are illustrated in fig 3.3 and 3.4. 
Figure 33 N2 : Involvement of ipsilateral mediastinal and/or subcarinal lymph 
nodes. (From Mountain CF. A new international staging system for lung 
cancer. Chest 1986; 89:225S-233S. Used by permission of The American 
College of Chest Physicians.) 
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Figure 3.4 N3 : Involvement of contralateral or ipsilateral scalene or supraclavicular 
lymph nodes; contralateral mediastinal or contralateral hilar lymph 
nodes. (From Mountain CF. A new international staging system for lung 
cancer. Chest 1986; 89:225S-233S. Used by permission of The American 
College of Chest Physicians.) 
In 1978 Naruke and colleagues described a practical system for regional 
lymph node mapping which is now generally used. Intrapulmonary, hilar 
and mediastinal lymph nodes are numbered from 1 to 14 according to their 
localization : 
Superior mediastinal 
1. superior mediastinal or highest mediastinal 
2. paratracheal 
3. pre- or retrotracheal 
3 a. pretracheal or anterior mediastinal 
3b. retrotracheal or posterior mediastinal 
4. tracheobronchial 
Aortic 
5. subaortic or Botallo's (aortic window) 
6. paraaortic (ascending aorta) 
Inferior mediastinal 
7. subcarinal 
8. paraesophageal (below carina) 
9. pulmonary ligament 
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Hilar or intrapulmonary 
10. hilar 
11. interlobar 
12. lobar : upper, middle and lower lobe 
13. segmental 
14. subsegmentai 
Relation of the most important lymph nodes to trachea and main bronchi 
is shown in fig 3.5. 
Figure 35 Relation of regional lymph nodes to trachea and main bronchi according 
toNaruke(1978). 
Lymph nodes 1 to 9 are classified as mediastinal lymph nodes (N2), and 10 
to 14 as hilar or intrapulmonary lymph nodes (N1). 
The system of Naruke allows precise description of metastatic lymph 
nodes. This is important in interpreting survival data according to lymph 
node involvement. In this way, survival data can be correlated exactly to 
regional lymph node involvement. 
3.2.3. M category (distant metastases) 
MO : no (known) distant metastasis 
Ml : distant metastasis present - specify site(s) 
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33. Stage grouping 
Stage grouping of the TNM subsets is as follows : 
Occult carcinoma 
Stage 0 
Stage I 
Stage II 
Stage Ша 
Stage ШЬ 
Stage IV 
TX NO MO 
Carcinoma in situ 
T1-2N0M0 
T1-2N1M0 
T3 N0-1 MO 
T1-3N2M0 
Any Τ N3M0 
T4 Any N MO 
Any Τ Any N Ml 
Stages I and Π are illustrated in fig 3.6 and 3.7; stages Ша and ШЬ in fig 
3.8 and 3.9. 
T2 NO MO 
Involving mamstem 
bronchus>2 cm. 
distal to carina 
T2 NO MO 
Involving 
visceral pleura 
T I NO MO 
Peripheral 
com" lesion 
Figure 3.6 Stage I disease. (From Mountain CF. A new international staging system 
for lung cancer. Chest 1986; 89:225S-233S. Used by permission of The 
American College of Chest Physicians.) 
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T2 N1 MO 
Involving visceral pleura 
and peribronchial and 
hilar lymph nodes 
T I N1 MO 
i 3 cm. Involving 
peribronchial 
lymph nodes 
(by direct 
extension) 
T2 N1 MO 
Involving main 
bronchus and hilar 
lymph nodes 
Figure 3.7 Stage II disease. (From Mountain CF. A new international staging system 
for lung cancer. Chest 1986; 89:225S-233S. Used by permission of The 
American College of Chest Physicians.) 
T3 NO MO 
Superior sulcus 
tumor 
T3 N1 MO 
Peripheral tumor 
involving chest 
wall and intra-
pulmonary 
lymph nodes 
T2 N2 MO 
> 3 cm. tumor 
involving 
ірз i lateral hilar 
and mediastinal 
lymph nodes 
Figure 3.8 Stage Ilia disease. (From Mountain CF. A new international staging 
systemfor lung cancer. Chest 1986; 89:225S-233S. Used by permission of 
The American College of Chest Physicians.) 
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T4 N3 MO 
Involvement of mediastinum, 
ipsilateral and) contralateral 
mediastinal lymph nodes. 
contralateral hilar nodes, 
supraclavicular lymph 
nodes 
Figure 3.9 Stage ¡lib disease. (From Mountain CF. A new international staging 
system for lung cancer. Chest 1986; 89:225S-233S. Used by permission of 
The American College of Chest Physicians.) 
Clinical staging, also called cTNM, is the best estimate of the extent of 
disease made prior to the institution of any therapy. Surgical-pathologic 
staging, referred to as pTNM, is determined from the pathologic examination 
of resected specimens and is the most accurate (Goldstraw, 1989; Fernando 
et al., 1990). 
All lung tumors in this study were classified according to this new 
international staging system just described. Staging was done 
postoperatively as pTNM according to the results of pathological 
examination. The patients who were not operated on were clinically staged 
as cTNM. 
For small cell lung carcinoma, besides TNM staging, distinction is made 
between limited and extensive disease. Limited disease refers to a primary 
tumor confined to one hemithorax with ipsilateral or contralateral hilar, 
mediastinal or supraclavicular lymph node metastases, or pleural effusion. 
Extensive disease is defined as the presence of any more distant spread 
such as metastases in the contralateral lung or metastases in the brain, 
bones, liver, adrenal glands etc. There are, however, inconsistencies in the 
use of the terms limited and extensive, and the need for greater specificity 
for these groups of patients has been emphasized (Bunn et al., 1977). 
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4.1. Introduction 
4.1.1. Diagnosis and staging of bronchogenic carcinoma 
Accurate preoperative staging of bronchogenic carcinoma is essential as it 
determines treatment and ultimate prognosis. Noninvasive diagnostic 
methods used in this regard are the chest fílm, sometimes supplemented by 
tomography in various planes, bronchoscopy with bronchial biopsy with 
cytologic studies, computed tomography, magnetic resonance imaging 
(MRI), gallium scintigraphy and various scanning and ultrasonic techniques 
used to exclude distant metastases. Sometimes pulmonary angiography is 
used. Invasive staging of the mediastinum is possible by cervical 
mediastinoscopy, extended cervical mediastinoscopy, parasternal 
mediastinoscopy or anterior mediastinotomy. 
The routine chest film may show a mass that arises centrally around the 
hilar region or more peripherally in the lung parenchyma, although lung 
cancer can be radiographically occult. In some patients a pneumonic 
infiltrate may be present, in others a pleural effusion or an atelectatic lobe 
or segment in case of an obstructing bronchial tumor. 
Coin lesions occur as isolated masses in the peripheral field of a lung and 
are mostly asymptomatic. Sometimes tomography in various planes is 
helpful in delineating the location and extent of the lesion more precisely. 
However, routine chest films are not very reliable for staging of the 
mediastinum. In one study equivocal roentgenograms comprised 45% of 
patients of whom 42% proved to have mediastinal metastases (Paris et al., 
1975). Better results have been reported with hilar tomography in various 
planes but this requires a specially trained radiologist to achieve reproducible 
results. Tomography in this setting has largely been replaced by computed 
tomography (Heelan et al., 1987). 
Bronchoscopy is essential for preoperative visualization of the tumor and 
to take biopsies for histologic examination. 
It provides a direct inspection of the larynx, vocal cords, trachea and 
bronchi and allows the collection of secretions, washings and brushings for 
bacteriologie and cytologic study. Removal of suspicious tissue usually 
yields a histologic diagnosis. 
Sputum cytology, bronchoscopy, bronchial biopsy, brushings and washings 
can, in combination, lead to a definite histologic diagnosis of lung cancer 
in 90 to 95% of patients (Chaudhary et al., 1978). 
In comparison with tomography, computed tomographic (CT) scanning of 
the thorax is better for assessing the mediastinum, pulmonary nodules, 
effusions, masses and chest wall invasion. Visualization is markedly 
enhanced by intravenous contrast. Dynamic scanning, in which contrast 
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medium is injected continuously during scanning, allows production of 
high-quality images (Heelan et al., 1987). In this way, a detailed assessment 
of local spread of the primary lesion as well as the mediastinum is possible. 
In preoperative staging of lung cancer, CT scanning usually includes the 
upper abdomen to detect metastases in the liver and adrenal glands. CT 
scanning of the brain readily detects cerebral metastases. 
For intrathoracic lesions that cannot be diagnosed by bronchoscopy, 
percutaneous transthoracic aspiration needle biopsy guided by CT scanning 
can often establish diagnosis. 
However, with regard to the hilar region and the mediastinum, CT scanning 
in itself provides no precise histologic diagnosis and there exists much 
controversy and discussion about the exact role of CT scanning and 
mediastinoscopy in the staging of mediastinal lymph nodes. This issue is 
explored more deeply in paragraph 4.2 where the accuracy of CT scanning 
is examined in identifying mediastinal lymph node metastases. 
In a recent study of CT scanning by Thermann and colleagues ( 1989) in 95 
consecutive patients with proven or suspected bronchial carcinoma, the 
sensitivity was found to be 89.3% and the specificity 96.2%, which is 
remarkably high. By performing only mediastinoscopy in patients with a 
positive CT scan, the authors state that about 70% of routine 
mediastinoscopies can be avoided. A commentary on this study is given in 
paragraph 4.3. 
In section 4.4 an evaluation is made of central tumoral invasion of left-
sided tumors, diagnosed on CT scanning. To give a more precise diagnosis 
and determine best treatment an extended form of diagnostic anterior 
mediastinotomy is described. 
Pulmonary angiography is useful in assessing tumoral involvement of the 
pulmonary artery. It has a complementary role when there is suspicion of 
invasion of mediastinal structures or the pulmonary artery (Unruh et al., 
1986). 
Gallium scintigraphy has been studied for staging of bronchogenic 
carcinoma and detection of lymph node metastases. However, gallium is 
taken up by primary and secondary lung tumors as well as benign 
inflammatory processes, while adenocarcinoma may concentrate gallium 
less than the other histological types. Precise differentiation between hilar 
and mediastinal metastases, which is important in determining exact 
treatment, is not possible. So, gallium scintigraphy nowadays plays no 
significant role in the preoperative staging of lung cancer (Unruh et al., 
1986). 
Other scanning techniques with radioactive tracers are used to delineate 
distant metastases, mainly in the liver and skeleton. The routine use of 
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multiorgan scans has been questioned and they are indicated when there is 
clinical suspicion of metastases or abnormalities in the liver function tests 
or serum calcium. Quantitative ventilation-perfusion lung scans are useful 
to predict postoperative lung function and plan operative strategy. 
Ultrasonography of the abdomen is helpful in detecting or confirming liver 
or adrenal metastases. 
Magnetic resonance imaging (MRI) has been introduced recently. It has 
some advantages over CT scanning as it does not use ionizing radiation, it 
provides images in various planes including frontal and sagittal views, and 
its inherent contrast resolution is much greater than that of CT scanning. 
Inherent disadvantages are the pronounced influence of respiratory and 
cardiac motion and blood flow in the great thoracic vessels on imaging and 
the fact that osseous structures such as the ribs, are not so well visualized 
(Heelanetal., 1987). 
For the moment, MRI of the thoracic region offers no distinct advantages 
over CT scanning in the preoperative staging of bronchogenic carcinoma 
except for tumors of the superior sulcus and the diaphragmatic surface. In 
these special areas the coronal and sagittal views are particularly 
advantageous (Musset et al., 1986). 
However, precise detection of mediastinal lymph node metastases by MRI 
is not possible (Glazer et al., 1988; Ranade et al., 1990). 
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4.2.1. Abstract 
To determine more precisely the role of mediastinoscopy in the preoperative 
staging of bronchogenic carcinoma, we studied 85 patients in the period 
1983 to 1985 and compared the results of mediastinoscopy and computed 
tomographic scanning with the findings at thoracotomy. Mediastinoscopy 
was performed in 48 patients when mediastinal nodes larger than 1 cm were 
found at computed tomographic scanning. Only 21 of them (44%) were 
found to have metastatic nodes. Of the remaining patients, 22 were 
operated on and two showed false negative results (9%). Mediastinoscopy 
had a sensitivity of 91 % and a specificity of 100%. The positive predictive 
value of computed tomographic scanning was only 54%. Thirty-seven 
patients underwent thoracotomy after having negative computed 
tomographic scan results. Eleven of them (30%) were found to have 
metastatic mediastinal lymph nodes. The negative predictive value of 
computed tomographic scanning was 70%. When results from both series 
of patients were compared, the sensitivity and specificity of computed 
tomographic scanning proved to be 68% and 57%, respectively, with an 
accuracy of 61 %. Because of the low accuracy rate of computed tomographic 
scanning, a more routine use of mediastinoscopy seems to be justified. 
4.2.2. Introduction 
The indications for mediastinoscopy, including many intrathoracic diseases 
such as lymphomas and granulomatous disease, have been established. 
However, much controversy exists as to the precise role of mediastinoscopy 
in the preoperative staging of bronchogenic carcinoma. When this disease 
induces involvement of mediastinal lymph nodes, and thus becomes an N2 
status disease, curative resection is generally impossible and a thoracotomy 
should be avoided especially in cases with extranodal, high paratracheal, 
or contralateral involvement. Thus thorough preoperative evaluation of the 
mediastinum is mandatory either noninvasively by computed tomographic 
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(CT) scanning and magnetic resonance imaging (MRI) or invasively by 
cervical or anterior mediastinoscopy. It is often stated that those newer 
imaging techniques offering a high resolution will replace mediastinoscopy. 
The presence or absence of enlarged lymph nodes at CT scanning or MRI 
could in this way make mediastinoscopy unnecessary. We conducted a 
retrospective study to determine the value of mediastinoscopy and CT 
scanning in the preoperative staging of bronchogenic carcinoma. 
4.2 J . Methods 
A total of 85 patients with bronchogenic carcinoma, confirmed by biopsy, 
was studied. All underwent CT studies, which were performed on a Pfizer 
AS&E CT450 (Pfizer Medical Systems, American Science and Engineering, 
Inc., Cambridge, Mass.) ora CGR Koch & Sterzel GmbH & Co. CE 10,000 
scanner (Essen, Republic of West Germany) with contiguous 1 cm slices 
of the mediastinum. Routine intravenous contrast enhancement was used. 
Mediastinoscopy was performed routinely in those 48 patients in whom 
lymph nodes larger than 1 cm were detected at CT scanning of the 
mediastinum (Breyer et al., 1984; Brion et al., 1985; Daly et al., 1984; 
Imhof et al., 1985; Lewis et al., 1982; Richey et al., 1984; Unruh et al., 
1986). When metastatic nodes were visualized and confirmed histologically, 
no thoracotomy was undertaken. In the opposite case, a thoracotomy was 
performed. 
Our study is divided into two parts (Fig.4.2.1) : in the first part results are 
examined of mediastinoscopic studies performed after enlarged nodes 
greater than 1 cm were found on CT scanning, and in the second part the 
findings at thoracotomy are studied in patients in whom the results of CT 
scanning were negative. 
The study is retrospective, and cases occurring between 1983 and 1985 are 
examined. In the first part of the study, 48 patients were eligible for 
inclusion (table 4.2/1). These patients underwent mediastinoscopy by the 
cervical (n = 46) or anterior (n = 2) route; 46 were men and two were 
women. The mean age was 60.5 years with a standard deviation of 7.5 years 
and a range from 41 to 74; 18 tumors were left-sided and 30 right-sided. 
Histologic classifications are shown in table 4.2/1. The only complication 
of the procedure was a rather severe bleeding of a mediastinal vein, which 
was controlled by tamponade. 
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CT SCANNING OF MEDIASTINUM 
PART Π 
negarive 
( nodes й 1 cm ) 
η = 37 
THORACOTOMY 
/ \ 
positive negative 
nodes nodes 
η =11 η = 26 
FN TN 
Figure 42.1. Procedure followed in our department for preoperative staging of 
bronchogenic carcinoma showing the two parts of present study. At the 
bottom are shown results for mediastinoscopy and CT scanning. (TP, 
true positive; FP, false positive; FN, false negative; TN, true negative). 
In the second part of the study, 37 patients who had negative CT scan results 
were operated on during the same period (table 4.2/1). Thirty-three were 
men and four were women. The mean age was 62.1 years with a standard 
deviation of 5.8 years and a range from 55 to 76; 22 tumors were left-sided 
and 15 right-sided. Histologic classifications are shown in table 4.2/1. 
During thoracotomy a systematic search for lymph nodes in the mediastinum 
was undertaken. 
The sensitivity, specificity and accuracy of mediastinoscopy and CT 
scanning were calculated according to the method of Galen. 
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n=85 
PARTI 
positive 
( nodes > 1 cm ) 
η = 48 
MEDIASTINOSCOPY 
( pathological examination ) 
positive 
η = 21 
negative 
η = 27 
NO THORACOTOMY THORACOTOMY 
N = 22 
/ \ 
/ \ 
positive negative 
nodes nodes 
n = 21 n = 0 n = 2 n = 20 
MEDIASTINOSCOPY: TP FP FN TN 
CTSCANNING: TP FP TP FP 
Table 4.211. Patient population characteristics in parts I and II of study 
Years No. 
Part I : CT scan results positive 
Total patients 48 
Men 46 
Women 2 
Age 
Mean 60.5 
Standard deviation 7.S 
Range 41-74 
Histologic types 
Squamous cell carcinoma 25 
Adenocarcinoma 9 
Small cell carcinoma 8 
Carcinoid 1 
Undifferentiated carcinoma 5 
Left-sided tumors 18 
Right-sided tumors 30 
Part II : CT scan results negative 
Total patients 37 
Men 33 
Women 4 
Age 
Mean 62.1 
Standard deviation 5.8 
Range 55-76 
Histologic types 
Squamous cell carcinoma 24 
Adenocarcinoma 8 
Carcinoid 2 
Undifferentiated carcinoma 3 
Left-sided tumors 22 
Right-sided tumors 15 
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4.2.4. Results 
Results among patients who had positive results of the CT scan (n=48) are 
shown in fig. 4.2.1. Of the 48 mediastinoscopic procedures performed, 
44% showed positive results (21 patients), that is, metastatic glands were 
found on pathologic examination. Assuming there were no false positive 
histologic results, this constituted true positive results in these 21 patients. 
Twenty-seven biopsy specimens were found to be negative for metastatic 
disease. Twenty-two of these patients with negative results underwent 
thoracotomy; the other five patients had a contraindication to thoracotomy 
or refused operation. In two patients undergoing thoracotomy, metastatic 
mediastinal nodes were found, for a total of two (9%) false negative results. 
Results at thoracotomy in the other 20 were truly negative. Data were 
calculated for 43 patients (table 4.2/2); because we had no histologic results 
of a biopsy specimen taken at thoracotomy, the five patients who were not 
operated on were excluded. 
Mediastinoscopy had a sensitivity of 91%, a specificity of 100% and an 
accuracy of 95%. 
Looking at the results for CT scanning, 20 false positive results were found; 
these were the patients whose results on mediastinoscopy were truly 
negative. The total number of true positive results of CT scans was equal 
to the number of true positive and false negative results of mediastinoscopic 
examinations : both totaled 23. From these data (table 4.2/2), the positive 
predictive value of CT scanning was calculated to be 54%. The combination 
of CT scanning and mediastinoscopy proved to have a far higher specificity, 
inasmuch as many enlarged glands were found not to be metastatic on 
pathologic examination. 
Of the 37 patients with negative results of CT scanning (fig. 4.2.1), 11 
(30%) were found to have false negative results with metastatic mediastinal 
lymph nodes that could possibly have been detected by mediastinoscopy; 
26 (70%) had true negative results. Calculations are shown in table 4.2/2. 
The negative predictive value of CT scanning was 70%. Combining the 
results for patients having positive or negative results to CT scan, 80 
patients in all, the sensitivity and specificity of CT scanning were 68% and 
57%, respectively, with an overall accuracy of 61%. Thus not only the 
specificity but also the sensitivity of computed tomography appear to be 
lower than is generally accepted (Breyer et al, 1984; Brion et al., 1985; 
Daly et al., 1984;Imhof et al., 1985;Lewis et al., 1982; Richeyet al., 1984). 
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Table 4.2/2. Combined results for CT scanning and mediastinoscopy 
(calculations from Fig.42.1) 
Mediastinoscopy 
21 
Sensitivity: — =91% 
23 
20 
Specificity : — = 100% 
20 
41 
Accuracy : — = 95% 
43 
CT scanning 
23 
Positive predictive value : — = 54% 
43 
26 
Negative predictive value : — = 70% 
37 
23 
Sensitivity : = 68% 
34 
26 
Specificity: — =57% 
46 
49 
Accuracy : — =61% 
80 
Formulas 
TP 
Sensitivity = 
TP + FN 
TN 
Specificity = 
TN + FP 
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TP + TN 
Accuracy = 
TP + TN + FP + FN 
TP 
Positive predictive value = 
TP + FP 
TN 
Negative predictive value = 
TN + FN 
TP, true positive; FN, false negative; FP, false positive; TN, true negative 
4.2.5. Discussion 
The purpose of mediastinal imaging and mediastinoscopy is to give the 
most accurate assessment of mediastinal involvement, thus limiting the 
number of unnecessary thoracotomies, but at the same time to provide the 
greatest chance of thoracotomy to a patient with a potentially curable 
disease. Mediastinoscopy was described first in 1959 by Carlens, who 
proposed a cervical approach, and then in 1966 by McNeill and Chamberlain, 
who proposed an anterior approach. In the beginning mediastinoscopy was 
used as a routine procedure in the preoperative staging of bronchogenic 
carcinoma. Luke, Todd, and Cooper (1986) described 1000 patients who 
underwent mediastmoscopy during the period 1979tol984witha negligible 
morbidity and mortality. Mediastinoscopy showed positive histologic 
results in 29.6% of patients and so was found a valuable tool to select 
patients for operation. 
With the introduction of CT scanning, a precise visualization of the 
mediastinum became possible; this led to the assumption that enlarged 
glands could be considered to be metastatic nodes and that, when no glands 
were discovered, a thoracotomy could safely be performed. 
However, several studies demonstrated that enlarged glands are not 
necessarily metastatic and that histologic proof was mandatory before a 
patient was judged inoperable.(Breyer et al., 1984;Brionetal., 1985; Daly 
et al., 1984; Imhof et al., 1985; Lewis et al, 1982; Richey et al., 1984; 
Unruh et al., 1986). Brion and associates (1985), for instance, studied 153 
patients with bronchogenic carcinoma in whom CT scanning and 
mediastinoscopy were prospectively performed. The sensitivity of CT 
scanning was 89% and die specificity only 46%. The results of our study, 
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which was designed on the same assumptions as those of Brion and 
associates (1985) confirm these findings. Indeed, the positive predictive 
value of CT scanning was found to be only 54%. 
But is the sensitivity of CT scanning really that high ? Recently McKenna 
and colleagues (1985) demonstrated that with careful mediastinal dissection 
during thoracotomy, nodes smaller than 1 cm may be found that indeed 
prove to contain metastatic disease. These smaller glands are likely to be 
missed on CT scanning, inasmuch as slices are routinely taken every 1 cm. 
In the prospective study by McKenna and colleagues (1985), CT scanning 
could not detect 40% of all nodal metastases. The sensitivity and specificity 
of CT scanning were found to be 60%. In a similar retrospective study, 
Rhoads and colleagues (1986) calculated the sensitivity and specificity of 
CT scanning to be 57% and 69%. As we have in our study, both groups of 
authors concluded that computed tomography cannot replace 
mediastinoscopy and, because of the low sensitivity, cannot even select 
those patients who should have a mediastinoscopy. 
Will MRI change anything in our attitude ? In a report from the Mayo 
Clinic, MRI was not found to be superior to CT scanning in imaging the 
mediastinum (Baker et al., 1985). Larger time intervals are necessary to 
obtain the images and thus interference with respiration occurs, although 
coronal and sagittal views are possible. Moreover, lymph nodes less than 
1 cm seem equally difficult to detect, because mediastinal fat gives such a 
strong signal that it can mask normal lymph node signals (Poon et al., 
1986). 
On the basis of our results and those of other reports, we suggest the 
following guidelines (table 4.2/3) concerning the use of mediastinoscopy 
at the present time [see also paragraph 4.5. Comment]. Mediastinoscopy 
is unnecessary in patients with a peripheral squamous cell carcinoma and 
with undiagnosed nodules smaller than 3 cm.(Jolly et al., 1980). Cervical 
mediastinoscopy should be performed in patients with centrally located 
squamous cell carcinoma on the right side and in every patient with an 
undifferentiated carcinoma and an adenocarcinoma except for those in the 
left upper lobe of the lung and centrally located tumors on the left side. 
Anterior mediastinoscopy is indicated with tumors of the left upper lobe of 
the lung (Page et al., 1980) and with centrally located tumors on the left 
side; when results of mediastinoscopy by the anterior route are negative in 
patients in this last group, a cervical mediastinoscopy should be performed, 
because centrally located tumors can give rise to metastases in the left 
paratracheal and subcarinal nodes without involvement of anterior 
mediastinal glands (Jolly, 1982). 
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Table 4.213. Actual guidelines f or the use of mediastinoscopy 
No mediastinoscopy 
Peripheral squamous cell carcinoma 
Undiagnosed peripheral nodule < 3 cm 
Cervical mediastinoscopy 
Right-sided centrally located squamous cell carcinoma 
Every undifferentiated carcinoma and adenocarcinoma (except for left 
upper lobe and left central tumors) 
Anterior mediastinoscopy 
Left upper lobe tumors 
Left-sided centrally located tumors (when anterior mediastinoscopy is 
negative, a cervical approach should be performed) 
Note : see also paragraph 4.5. Comment 
In conclusion, we can state that whenever enlarged nodes are found on CT 
scanning, mediastinoscopy is necessary to give histologic proof of true 
metastatic disease. Moreover, because of the rather low sensitivity and 
specificity of CT scanning, computed tomography cannot replace 
mediastinoscopy, and a more liberal use of mediastinoscopy seems to be 
justified in the routine preoperative staging of bronchogenic carcinoma. 
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4.3. Computed tomography in selecting patients for mediastinoscopy 
This paragraph was published as a letter to the editor in the Annals of 
Thoracic Surgery 1990; 50:163. It is a commentary on the article by 
Thermann and colleagues (1989) in which CT scanning was found a 
valuable tool in selecting patients for mediastinoscopy. By performing only 
a mediastinoscopy inpatients with a positive CT scan, these authors state 
that about 70% of routine mediastinoscopies can be avoided. 
To the editor : 
I read with great interest the study by Thennann and associates (1989) in 
which computed tomography was found a valuable selection method for 
mediastinoscopy. In a similar study from our institution (Van Schil et al., 
1989) we reached different conclusions and recommended mediastinoscopy 
as a routine procedure in the preoperative staging of bronchial carcinoma. 
These results were also observed by others authors (McKenna et al., 1985; 
Rhoads et al., 1986), who concluded that computed tomography cannot 
select those patients who should have a mediastinoscopy because of its low 
sensitivity and specificity. 
In the study of Thermann and associates (1989), the sensitivity and 
specificity of computed tomography are remarkably high (89.3% and 
96.2%, respectively). The inclusion in the study of 12 patients with benign 
lesions and, on the other hand, the exclusion of 14 patients (14.7% of the 
total group) who had bronchial carcinoma but did not undergo mediastinal 
lymphadenectomy for various reasons could introduce a certain bias. In my 
opinion, stratification of the results for benign and malignant disease, 
which was not made in the present study, could settle this issue more 
clearly. In this way the sensitivity and specificity of computed tomography 
in the staging of bronchial carcinoma, which is more interesting in this kind 
of discussion, could be quite different. 
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Reply by M.Thermann, MD 
To the Editor : 
A prospective study has to follow the protocol. The protocol of our study 
demanded preoperative staging procedures for all patients presumed to be 
operable for proven or suspected lung cancer. Therefore, the patients who 
had no malignancy in the definitive histological examination were included 
for they underwent the same staging procedures. The results of these 
patients can serve as a kind of control group. Looking only at the patients 
with postoperatively proven carcinoma denies the problems of preoperative 
staging procedures (as, for example, mediastinoscopy in a patient with a 
benign disease). 
The fact that patients were excluded for not fulfilling the protocol was a 
necessary part of a prospective study, where all patients admitted to the 
hospital were included. Patients were only evaluated when they had an 
intraoperative mediastinal lymph node dissection to get the most precise 
information about mediastinal lymph node involvement. Therefore, our 
protocol seems to be a good way to reduce (and not to introduce) bias. 
But the main point of disagreement of the two studies is the discrepancy in 
the results of the two staging methods. Mediastinoscopy in the Belgian 
group has an extraordinarily high sensitivity of 91 %, whereas in our group 
sensitivity is 79% (Thermann et al., 1984). On the other hand, computed 
tomography (CT) for mediastinal lymph nodes in the Belgian study has a 
sensitivity of 68% and a specificity of 57% (accuracy, 61 %), which is poor. 
Three studies report accuracy rates between 81% and 88% (Daly et al., 
1984; Hajek et al., 1985; Modini et al., 1982). No details are reported from 
the Belgian group as to who performed the evaluation of the CT scans. In 
our prospective study two experienced radiologists who are co-authors 
(R.B, E.W) were challenged by the surgeons, sometimes repeating unclear 
CT examinations using the identical scanner. 
We completely agree with the Belgian authors that, on the basis of their 
superb mediastinoscopy and their poor CT results, distrust in CT is 
acceptable, although their conclusion is not helpful in the single case ("a 
more liberal use of mediastinoscopy seems to be justified"). But as the 
technical aspects of computed tomography improve (and, as we hope, 
those of magnetic resonance imaging) and images become more precise, 
the accuracy of the radiologist will increase. 
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Therefore, we believe that our conclusions are an acceptable mid-position 
between the opinions of the "mediastinoscopists" and the "resectionists". 
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4.4.1. Abstract 
From June 1987 to June 1990, an anterior mediastinotomy with opening of 
the pericardium was performed in 11 patients (mean age 67.8 years) to 
evaluate resectability of left-sided centrally located bronchogenic 
carcinoma. 
In 3 patients (27.3%), extensive intrapericardial involvement was found 
which precluded complete resection. Intrapericardial extension without 
complete invasion of the pulmonary vessels was present in 2 patients 
(18.2%) who subsequently underwent an intrapericardial pneumonectomy. 
In 6 patients (54.5%) no intrapericardial tumor was present. 
There was no perioperative mortality. One patient required redrainage of 
the pleural cavity because of a postoperative pneumothorax. 
In total, 4 patients (36.4%) underwent intrapericardial pneumonectomy, 6 
(54.5%) were treated by radiotherapy and 1 (9.1%) by chemotherapy. 
In left-sided, centrally located tumors opening the pericardium during 
anterior mediastinotomy yields additional information about the degree of 
tumor invasion and the feasibility of performing an intrapericardial 
pneumonectomy. In this way unnecessary thoracotomies are avoided. 
4.4.2. Introduction 
Left anterior mediastinotomy is a well established method of detecting 
metastatic disease in subaortic or paraaortic lymph nodes and evaluating 
tumor fixation to mediastinal structures especially in left upper lobe 
neoplasms (Goldstraw, 1988; Page et al., 1980; Schreinemakers et al., 
1988). In our experience, opening the pericardium during anterior 
mediastinotomy has been found helpful in detecting intrapericardial 
extension and determining the resectability of left-sided central tumors 
without performing an exploratory thoracotomy. 
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4.43. Material and methods 
Technique 
A horizontal incision over the third costal cartilage is made. After splitting 
the pectoral muscle, the second interspace is identified. If it is large 
enough, the intercostal muscles are divided without rib resection. To 
facilitate exposure, resection of the third costal cartilage is usually necessary. 
The internal mammary vessels are preserved if possible. By blunt 
dissection, the pleura is dissected off laterally, the pericardium is identified 
and opened vertically for 4-5 cm. Any pericardial fluid found is aspirated 
for cytological examination. With digital exploration and visual inspection, 
intrapericardial tumor extension and growth into the pulmonary vessels or 
aorta are evaluated. A mediastinoscope is introduced into the pericardium 
to visualize any suspicious area and, if necessary, biopsies are taken. When 
there is central extension, the possibility of performing an intrapericardial 
pneumonectomy is evaluated. Precise examination of the non-invaded 
pulmonary artery segment is easy. 
Samples of subaortic and paraaortic lymph nodes are taken. 
The pericardium is closed with several interrupted stitches and a drain is 
left in the pleural space if the pleura has been opened. 
Patients 
From June 1987 to June 1990, 34 patients underwent anterior 
mediastinotomy. In 11 (32.3%), the pericardium was opened to evaluate 
intrapericardial extension of a left-sided bronchogenic carcinoma (table 
4.4/1). They were all men. The mean age was 67.8 ±8.1 years (range 57-
81). All patients had preoperative CT scanning of the thorax which 
suggested central invasion of hilar or mediastinal structures or pulmonary 
vessels (fig.4.4.1). Three patients had recurrent tumor, 2 after lobectomy 
and 1 after sleeve lobectomy of the left upper lobe. 
In three patients no definite histological diagnosis could be made 
preoperatively. 
Eight patients (72.7%) underwent cervical mediastinoscopy to rule out 
metastatic disease in paratracheal, tracheo- bronchial or subcarinal lymph 
nodes. 
In all patients, staging was done after anterior mediastinotomy according 
to the TNM classification of the American Joint Committee for Cancer 
Staging (Mountain, 1987). 
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Table 4.411. Diagnosis in patients undergoing anterior mediastinotomy with opening of the pericardium. 
N 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Age 
57 
75 
60 
67 
72 
62 
58 
81 
71 
65 
77 
Diagnosis 
centrally located tumor in left 
upper lobe 
left central tumor after lobectomy 
of left upper lobe in 1974 
left central tumor 
tumor in ostium of left upper lobe 
recurrent tumor after lobectomy of 
left upper lobe in 1988 
tumor in ostium of left upper lobe 
recurrent tumor after sleeve 
lobectomy of left upper lobe in 1986 
left central tumor 
tumor in ostium of left upper lobe 
left central tumor 
left central tumor 
Histology 
squamous cell carcinoma 
no diagnosis 
squamous cell carcinoma 
small cell carcinoma 
adenocarс inoma 
squamous cell carcinoma 
no diagnosis 
squamous cell carcinoma 
squamous cell carcinoma 
no diagnosis 
squamous cell carcinoma 
Cervical 
mediastinoscopy 
none 
none 
negative 
negative 
none 
negative 
negative 
negative 
negative 
negative 
negative 
Figure 4.4.1. CT scan of the thorax showing tumor in contact with the origin of the 
left pulmonary artery. Intrapericardial pneumonectomy was possible 
in this case (A: ascending aorta; PA: pulmonary artery; T: tumor) 
4.4.4. Results 
The results of anterior mediastinotomy with respect to lymph node 
involvement and central tumor extension are shown in table 4.4/2. In 3 
patients without a preoperative histological diagnosis, this was established 
during anterior mediastinotomy. The histology was squamous cell 
carcinoma in 8 patients (72.7%), adenocarcinoma in 2 (18.2%) and small 
cell carcinoma in 1 (9.1%). 
Intrapericardial invasion of the pulmonary vessels precluding radical 
surgical treatment was found in 3 patients (27.3%). These were treated by 
radiotherapy. Extension into the pericardium without complete invasion 
of the pulmonary vessels was present in 2 patients. These underwent 
intrapericardial pneumonectomy. In 6 patients, there was no intrapericardial 
tumor. 
In 4 patients, metastatic lymph nodes were found at Naruke sites 5 or 6 
(Narukeet al, 1978). 
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Table 4.412. Findings at anterior mediastinotomy 
H 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Anterior Mediaetinotoey Findings 
N 5,6 
+ 
+ 
-
+ 
-
-
— 
-
+ 
-
-
intraperlcardial invasion of PA 
aortic arch invasion, no intra­
perlcardial extension; biopsy ι 
squamous cell carcinoma 
invasion of pericardium but no 
extension to PA or PV 
tumor extension to pericardium 
but no invasion 
no intraperlcardial extension 
intraperlcardial invasion of PA 
no intraperlcardial extension; 
extensive invasion of thoracic 
wall; biopsy ι squamous cell 
carcinoma 
no intraperlcardial extension; 
invasion of first rib 
complete invasion of PA intra-
pericardially 
invasion of pericardium but not 
PA or PV; biopsy : adenocarcinoma 
no intraperlcardial extension 
TUM 
T4N2M0 
T4N2M0 
T3N0M0 
T2N2M0 
T3N0M0 
T4N0M0 
T4NOM0 
T4N0M0 
T4N2M0 
T3N0M0 
ТЗИ0М0 
Stage 
III В 
III В 
III A 
III A 
III A 
III В 
III В 
III В 
III в 
III A 
III A 
Treatment 
radiotherapy 
radiotherapy 
intraperlcardial 
pneumonectomy with partial 
pericardial excision 
chemotherapy 
intraperlcardial completion 
pneumonectomy 
radiotherapy 
radiotherapy 
radiotherapy 
radiotherapy 
intraperlcardial 
pneumonectomy with partial 
pericardial excision 
intraperlcardial 
pneumonectomy 
N 5,6 : lymph node sites 5 and 6 according to Naruke (1978); 
PA : pulmonary artery ; PV : pulmonary veins 
There was no perioperative mortality associated with anterior 
mediastinotomy. Subcutaneous emphysema and pneumothorax developed 
in 1 patient (9.1%) necessitating redrainage of the pleural cavity. 
In total, 4 patients (36.3%) underwent intrapericardial pneumonectomy, 1 
of which was a completion pneumonectomy. Two patients were operated 
upon at the same time as the mediastinotomy, the 2 others at an interval of 
6 and 8 days, respectively, after the definitive result of the biopsies. 
Six patients (54.6%) were treated by radiotherapy and 1 patient (9.1%) 
with small cell carcinoma received chemotherapy. 
4.4.5. Discussion 
The accurate preoperative determination of resectability of centrally 
located bronchogenic carcinoma remains difficult using only noninvasive 
techniques although the methods have been refined in recent years. 
CT scanning of the thorax is helpful in localizing the tumor and its extent 
and in determining the presence of enlarged nodes (Unruh et al., 1986). 
However, metastatic spread to mediastinal lymph nodes is difficult to 
determine. Small mediastinal node metastases remain undetected on CT 
scanning (McKenna et al., 1985). For the same reason, precise evaluation 
of tumor growth into the pulmonary vessels or the superior vena cava is 
often not possible, even when slices are taken every 5 mm (Bonnette et al., 
1988). Angiography of the pulmonary artery (with left anterior oblique 
views on the left side) is sometimes more helpful, but a histological 
diagnosis is still not possible and judgment of the length of pulmonary 
artery free of tumor is difficult. Moreover, the pulmonary veins and left 
atrial wall are not properly visualized (Unruh et al., 1986). Invasive 
techniques are therefore useful as a staging procedure. 
Anterior mediastinotomy, introduced by Mc Neill and Chamberlain in 
1966, has proven to be a valuable procedure for evaluation of subaortic and 
paraaortic lymph nodes, especially in left upper lobe tumors (Goldstraw, 
1988; Page et al., 1980; Schreinemakers et al., 1988). In our institution it 
is performed when extensive involvement of these nodes is present on CT 
scanning or when invasion of the pericardium or pulmonary vessels on the 
left side is suspected. 
During anterior mediastinotomy, fixation to mediastinal structures can be 
evaluated. Opening of the pleural space with inspection of hilar structures, 
so-called hilioscopy, gives additional information about the hilum and 
pleural cavity (Paris et al., 1979; París et al., 1985). Further evaluation of 
resectability is obtained by opening the pericardium which can be easily 
performed after pushing the pleura laterally. Digital palpation and inspection 
reveals any intrapericardial extension and the possibility of clamping the 
pulmonary vessels proximal to the area of tumor invasion is evaluated. A 
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decision regarding the feasibility of intrapericardial pneumonectomy can 
thus be made. If pericardial fluid is present, it is aspirated for cytological 
examination. The mediastinoscope can be introduced into the pericardium 
for further inspection and biopsies taken, if necessary (e.g. when no 
histological diagnosis has been made preoperatively). This was the case in 
3 patients (27.3%). Indications for opening the pericardium during anterior 
mediastinotomy are for centrally located tumors on the left side in which 
CT scanning suggests hilar or mediastinal involvement or invasion of the 
wall of the pulmonary vessels (fig.4.4.1). A decision regarding definitive 
treatment was possible after intrapericardial evaluation in 7 patients 
(63.6%) in this series. When the decision to perform a pneumonectomy has 
been made, this can be done at the same session or scheduled shortly 
afterwards to prevent adhesions and scar formation. 
Subcutaneous emphysema with a pneumothorax necessitating redrainage 
of the pleural cavity was the only postoperative complication in 1 patient 
(9.1%) in this series. 
Pericardioscopy with introduction of the mediastinoscope through a 
subxiphoidal approach has been described to explore the pericardial cavity, 
aspirate fluid for cytological examination and take biopsies (Azorin et al., 
1988). However, inspection of the left pulmonary artery by this route is not 
possible. Retained left atrial catheters have been removed by a subxiphoidal 
approach with the use of a mediastinoscope (Behl et al., 1984). 
Anterior mediastinotomy is not only a staging procedure for bronchogenic 
carcinoma but has also been used to take pericardial biopsies, perform 
fenestration, to implant epicardial pacemaker electrodes and remove a 
pericardial cyst and hamartoma (Jolly et al., 1973; Martigne et al., 1989). 
High paratracheal, extranodal or contralateral involvement of mediastinal 
lymph nodes has been accepted as a contraindication to surgical treatment. 
Controversy still exists in adenocarcinoma with metastases to mediastinal 
lymph nodes as prognosis is poor in these cases (Hashim et al., 1982). For 
these reasons, cervical mediastinoscopy is used as a routine procedure in 
the preoperative staging of bronchogenic carcinoma in our institution. 
Eight patients (72.7%) in our present series underwent cervical 
mediastinoscopy before or at the same time as anterior mediastinotomy. In 
3 patients, anterior mediastinotomy only was performed because of extensive 
involvement of subaortic nodes on CT scanning which proved to be 
metastatic in 1 case, and because of recurrent tumor after lobectomy in 2 
patients. 
In conclusion, anterior mediastinotomy with opening of the pericardium 
provides additional information regarding the resectability of left-sided 
central tumors and is valuable to determine whether intrapericardial 
pneumonectomy can be performed. Unnecessary thoracotomies are 
therefore avoided. 
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4.5. Comment 
4.5.1. Invasive staging of the mediastinum 
From the foregoing paragraphs it is clear that accurate preoperative clinical 
staging of lung cancer is not possible by noninvasive means alone. This 
issue was also dealt with in three recent reports which deserve special 
attention. 
In a group of 84 patients with presumable operable bronchogenic carcinoma, 
the chest radiograph, computed tomography (CT), magnetic resonance 
(MR) imaging and mediastinoscopy were compared prospectively as 
staging modalities to assess mediastinal lymph node status (Patterson et al., 
1987). AU patients underwent cervical mediastinoscopy. For lesions of the 
left upper lobe, anterior mediastinotomy or extended cervical 
mediastinoscopy (Ginsberg et al., 1987) were also performed to assess and 
sample the subaortic lymph nodes. Results of CT or MR scans were not 
made available to the thoracic surgeons. CT scans were considered positive 
if mediastinal node size exceeded 1 cm. Results are given in tables 4.5.1/ 
1 and 4.5.1/2. The classic chest radiograph had a very low specificity (43%) 
and overall accuracy rate (57%). The highest values were noted for 
mediastinoscopy with an overall accuracy of 95%. There was a high 
incidence of false negative CT and MR studies (29%), as was found also 
in our study, where 30% false negative results with CT scanning were 
found [paragraph 4.2]. So, Patterson and colleagues concluded that even in 
patients with negative CT results mediastinoscopy should be performed. It 
was recommended as a routine staging investigation in patients with 
bronchogenic carcinoma. 
Table 4 J.1/1 Sensitivity, specificity and accuracy of different staging 
modalities. 
chest radiograph 
CI' scan 
MR scan 
mediastinoscopy 
sensitivity 
81% 
71% 
71% 
87% 
specificity 
43% 
89% 
91% 
100% 
accuracy 
57% 
82% 
83% 
95% 
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Table 45.112 Positive and negative predictive value of different 
staging modalities. 
predictive value 
chest radiograph 
CT scan 
MR scan 
mediastinoscopy 
positive 
46% 
79% 
82% 
100% 
negative 
79% 
84% 
84% 
93% 
In a study of 418 patients with primary pulmonary carcinoma the accuracy 
of computed tomography in the stagmg of lung cancer was studied (Lewis 
et al., 1990). Preoperatively, each CT scan was analyzed for components 
of the current TNM stagmg system. Sensitivity and specificity of CT 
scanning for detection of mediastinal lymph node metastases were 84.4% 
and 84.1% respectively, with a positive predictive value of 68.7% and a 
negative predictive value of 92.9%. When TNM stages derived from CT 
scans were compared to postoperative TNM stages only 45.4% completely 
agreed. CT scanning overestimated the stage in 22.5% and underestimated 
in 19.4% of cases. It was shown that CT scanning of the chest cannot 
accurately stage primary lung carcinoma according to the current TNM 
classification. In this study, the negative predictive value of CT scanning 
was high (92.9%). So, it was concluded that invasive staging could be 
deferred for definitive thoracotomy when no lymphadenopathy was evident 
on CT. This is in marked contrast to the study of Patterson and our results 
[paragraph 4.2] where a high number of false negative CT scans were 
found. McKenna and colleagues in 1985 already demonstrated that with 
careful mediastinal dissection during thoracotomy, nodes smaller than 1 
cm may be found that indeed prove to contain metastatic disease. Moreover, 
CT scanning could not detect 40% of all nodal metastases; usually these are 
smaller glands which are likely to be missed on CT scanning, inasmuch as 
slices are routinely taken every 1 cm. 
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In 103 patients who underwent thoracotomy for lung carcinoma a clinical 
evaluative stage (cTNM) was obtained. Routine CT scanning was perfomied 
and cervical mediastinoscopy when the CT scan of the mediastinum 
suggested mediastinal invasion or lymphadenopathy greater than 1.5 cm. 
This was supplemented by left anterior mediastinotomy for tumors of the 
left upper lobe or left main bronchus (Fernando et al., 1990). A more 
accurate TNM staging was obtained after thoracotomy supplemented by 
detailed pathological examination (pTNM). In only 46.6% of patients 
cTNM and pTNM concurred. On comparing nodal staging, 55.3% of cases 
remained unchanged. In the patients thought to have no mediastinal gland 
involvement preoperatively, routine nodal dissection and subsequent 
pathological analysis showed metastasis to be present in the mediastinal 
lymph nodes of 23.5% of patients. So, it was concluded that cTNM remains 
only a crude evaluation and that the major component of preoperative 
evaluation is the exclusion of gross mediastinal gland involvement by 
invasive mediastinal exploration. 
4.5.2. Conclusion 
Accurate preoperative staging of the mediastinum still requires 
mediastinoscopy. In patients with lymph nodes greater than 1 cm on CT 
scanning (CT positive), mediastinoscopy is surely indicated to rule out 
metastatic disease. In patients with lymph nodes smaller than 1 cm on CT 
scanning (CT negative) opinions are more divided. 
However, when careful mediastinal lymph node dissection is performed 
during thoracotomy positive nodes are identified in up to 40% of patients 
with negative CT scan results, which is unacceptably high (McKenna et al., 
1985; Patterson et al., 1987; Van Schil et al., 1989). Nodes smaller than 1 
cm may indeed contain metastatic disease! At the Antonius Hospital, 
Nieuwegein, routine cervical mediastinoscopy is performed for precise 
mediastinal staging. At the University Hospital of Antwerp a more selective 
approach is used. Cervical mediastinoscopy is always performed in patients 
with centrally located tumors but not in case of a peripheral squamous cell 
carcinoma or an undiagnosed nodule smaller than 3 cm with negative 
nodes on CT scanning. 
In central left upper lobe tumors anteriormediastinoscopy or mediastinotomy 
is recommended in addition to cervical mediastinoscopy to identify 
metastatic disease in the periaortic and subaortic lymph nodes (Lacquet et 
al., 1990). Cervival and anterior mediastinoscopy can be combined in the 
so-called extended cervical mediastinoscopy (Ginsberg et al., 1987). To 
judge operability of left-sided centrally located tumors the pericardium can 
be opened during anterior mediastinotomy to determine whether or not an 
intrapericardial pneumonectomy can be performed (Van Schil et al., 1991 ). 
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Regarding the surgical implications of metastatic mediastinal lymph 
nodes, it is generally accepted that high paratracheal, extranodal or 
contralateral involvement of mediastinal lymph nodes is a contraindication 
to further surgical treatment. In a study by Bergh and Schersten in 1965, the 
5-year survival rate in resected lung carcinoma was only 4% when there 
was perinodal metastatic involvement of mediastinal lymph nodes. On the 
other hand, ipsilateral intranodal invasion at low tracheobronchial level in 
case of squamous cell carcinoma does not preclude surgical resection. This 
is also trae for a squamous cell carcinoma of the left upper lobe with 
metastatic intranodal involvement in the aortic window, found at left 
parasternal mediastinoscopy after negative cervical mediastinoscopy 
(Lacquet et al., 1990). Controversy still exists for adenocarcinoma with 
metastases to mediastinal lymph nodes, although prognosis is poor in these 
cases (Hashim et al., 1982). 
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5.1. History of sleeve resection 
Macewen performed the first pneumonectomy in 1895. The operation was 
done in multiple stages in a patient with severe tuberculosis, abscess and 
empyema of the left lung. The first successful one-stage pneumonectomy 
was performed in 1933 by Graham and Singer. 
In the 1930s and 1940s many surgeons joined the cult of "pneumonectomy 
only", meaning that it was the only accepted surgical procedure for 
bronchogenic carcinoma (Ochnsner et al., 1940). Lobectomy was initially 
only considered reasonable in patients with diminished pulmonary or 
cardiac reserve. In later years it was shown that lobectomy afforded 
survival rates similar to pneumonectomy if the lesion could be totally 
excised by lobectomy (Crabbe et al., 1989). 
One of the first bronchoplastic procedures was done in 1932 by Bigger who 
performed a bronchotomy to remove a tumor of the left main stem 
bronchus in a 14-year-old boy (Bigger, 1935). In 1939 an adenoma at the 
orifice of the left lower lobe was successfully removed by Eloesser, who 
did a bronchotomy, excised the adenoma and fulgurated its base (Eloesser, 
1940). 
In 1945 Sanger described his extensive experience in 1210 patients with 
chest wounds during World War IL He described two patients with a 
traumatic bronchopleural fistula due to injury of the right main bronchus. 
These were sucessfully treated by suturing the defect with silk and 
reinforcing it with muscle (Kittle, 1989). 
The first "sleeve" resection in a patient was done in 1947 by Price Thomas 
who removed a bronchial adenoma at the orifice of the right upper lobe 
(Thomas, 1954). Actually a wedge excision of the bronchus was performed. 
The patient was a Royal Air Force cadet and a pneumonectomy which was 
the only surgical alternative, would have prevented the patient from 
becoming a pilot. The operation was successful, the patient served as a pilot 
and was well 6 years postoperatively (Thomas, 1956). 
In 1950 Gebauer described 4 patients operated on for tuberculous 
bronchostenosis in which the stenotic area was opened longitudinally in its 
membranous portion, and an elliptical dermal graft stiffened by stainless 
steel wire was sutured in place (Gebauer, 1950). 
Acute bronchial rupture was repaired for the first time by Scannell (1951) 
in a 10-year-old boy struck by an automobile. With interrupted silk sutures 
a laceration of the membranous portion of the right main bronchus was 
repaired. In addition, the suture line was reinforced by a pleural flap. 
The first sleeve resection for bronchogenic carcinoma was done by Allison 
in 1952 in a patient who could not tolerate a pneumonectomy because of 
restricted pulmonary function. A lobectomy with sleeve resection of the 
main bronchus and removal of a segment of the pulmonary artery was 
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performed. However, Allison never reported this case himself (Thomas, 
1956). 
In 1953 Kiriluk and Merendino demonstrated the feasibility of different 
bronchial, tracheal and tracheobronchial resections and subsequent 
reconstructions (fig.5.1.1-5.1.3). They showed in this pioneering work that 
respiratory and ventilatory function of lung tissue distal to a resection and 
reconstruction was nearly normal. 
Figure 5.1.1. Representation of the planes of bronchial resection : two oblique and 
one transverse plane with section between cartilages. (FromKirilukLB, 
Merendino KA. An experimental evaluation in the dog of bronchial 
transplantation, bronchial, tracheal and tracheobronchial resection 
with reconstruction. Ann Surg 1953; 137:490-503. Used by permission 
ofJB. Lippincott Company.) 
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Figure 5.1.2. Representaíionofformsofbronchialandtrachealresection.AЯesection 
of a stem bronchus and the first bifurcation. BXesection of the carina. 
С andD.Carinal resection together with one stem bronchus and the 
entireexcludedlung.(FromKirilukLB,MerendinoKA.Anexperimental 
evaluation in the dog of bronchial transplantation, bronchial, tracheal 
and tracheobronchial resection with reconstruction. Ann Surg 1953; 
137:490-503. Used by permission ofJB. Lippincott Company.) 
Figure 5.1.3. A and B.Transplantation of a stem bronchus to the medial aspect of the 
contralateral stem bronchus.С andD.Transplantation of astern bronchus 
to the ipsilateral side of the trachea. (From KirilukLB, Merendino KA. 
An experimental evaluation in the dog of bronchial transplantation, 
bronchial.trachealandtracheobronchialresectionwithreconstruction. 
Ann Surg 1953; 137:490-503. Used by permission of J£.Lippincott 
Company.) 
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The technique of sleeve resection was brought to the United States by 
Paulson (1955), who introduced the term "bronchoplastic procedure". He 
reported 16 patients with traumatic, benign and malignant conditions that 
were treated successfully by bronchoplastic procedures. These included 
suturing of traumatic lacerations, dermal grafting for bronchostenosis and 
sleeve resection for bronchial adenoma and bronchogenic carcinoma. In 
lung cancer, sleeve resection was considered a compromise operation for 
patients who could not tolerate pneumonectomy because of limited 
pulmonary function. 
The first long-term results of sleeve lobectomy for lung cancer were 
presented in 1959 by Johnston and Jones. In appropriately selected patients 
results of sleeve resection were found to be equivalent to those of 
pneumonectomy. 
In an experimental study reported in 1974, Wood and colleagues 
demonstrated that oxygen uptake in the ipsilateral lung was deficient after 
sleeve lobectomy in contrary to simple lobectomy. The effect was most 
pronounced in the early postoperative period and normalized after4 weeks. 
With isotopie perfusion techniques a decreased perfusion of the remaining 
lung after sleeve lobectomy was shown. The exact cause of these findings 
is not known but they are probably related to surgical division of bronchial 
arteries, lymphatics or parasympathetic nerves, which stay intact in simple 
lobectomy. 
In 1986, Deslauriers and colleagues showed by ventilation/perfusion 
isotope scanning methods that after sleeve lobectomy the reimplanted lobe 
or lobes contribute significantly to overall lung function. 
Functional results of bronchial sleeve lobectomy were further studied by 
Angeletti and co-workers ( 1991 ). Pulmonary function tests and a quantitative 
perfusion lung scan were done preoperatively and repeated after 3 and 12 
months. It was shown that bronchial sleeve lobectomy caused no loss of 
pulmonary function. Lung function improved in a stepwise manner from 
3 to 12 months postoperatively. Moreover, analyzing the perfusion of each 
lung, the preserved, ipsilateral rather than the contralateral lobe or lobes 
contributed significantly to the improvement in overall perfusion. 
A review article of 565 bronchoplastic procedures performed between 
1947 and 1981 was written by Lowe and colleagues in 1982, adding 28 
patients of their own. Bronchoplastic procedures were found especially 
valuable for lesions in the proximal airways and were considered the ideal 
surgical therapy for benign endobronchial lesions, tumors of low-grade 
malignant potential and for repair of airway injuries. They were also found 
applicable to a select group of patients with carcinoma of the lung with 
long-term survival comparable to pneumonectomy. 
One of the largest series of bronchoplastic and angioplastic operations, 248 
in total, was published by Vogt-Moykopf and colleagues in 1986. Bronchial 
61 
sleeve resections were performed in 38% of patients, pulmonary arterial 
sleeves in 3% and double sleeves in 12%. A complete bronchial sleeve 
resection was found more adequate and subject to fewer complications 
than a partial sleeve resection. A maiked correlation was shown between 
the tumor stage and survival, 5-year survival rate of stages I and Π being 
38% and of stage Ш15%. Rather surprisingly, 5-year survival rate for NO 
disease was 37%, for N1 involvement 30% and for N2 disease 0%. A more 
detailed discussion of survival in relation to lymph node involvement is 
given in chapter 7. 
Although initially a compromise operation in lung cancer, further studies 
showed that sleeve resection was a valuable alternative to pneumonectomy 
in selected cases. Faber (1987) concluded that sleeve lobectomy should be 
the operation of choice whenever technically feasible. 
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6.1. Indications of bronchial sleeve resection 
Sleeve lobectomy was mitially mtroduced as a compromise operation for 
patients who could not tolerate pneumonectomy because of limited 
pulmonary function. However, it soon became clear that bronchial sleeve 
resections are feasible in a wide range of benign and malignant lesions. 
These are listed in table 6.1/1. In general, sleeve resection is indicated for 
centrally located lesions at the orifice of a lobar bronchus or in the main 
bronchus itself, for which the only surgical alternative is a pneumonectomy. 
All lobar and main stem bronchi are amenable to sleeve resection, although 
in most series there is a preponderance of lobectomy of the right upper lobe 
with sleeve resection of the main bronchus, the so-called right upper sleeve 
lobectomy. 
Table 6.111 Indications for bronchial sleeve resection 
Non-neoplastic lesions 
traumatic bronchial injuries 
posttraumatic and inflammatory strictures 
accidental operative injury or transection 
Benign endobronchial tumors 
Tumors of low-grade malignancy 
carcinoid tumor (centrally located) 
Malignant bronchial tumors 
squamous cell carcinoma (centrally located) 
peripheral tumor with metastatic hilar lymph nodes 
functionally compromised patients with malignant tumor 
(centrally located) 
Non-neoplastic lesions, in which a sleeve resection is indicated, are 
traumatic bronchial injuries and posttraumatic or inflammatory structures. 
Accidental operative transsection of a main bronchus during lobectomy 
was already repaired by sleeve resection described in 1950 by Belcher. 
Centrally located benign tumors and lesions of low-grade malignant 
potential, mostly typical carcinoid tumors, are ideal indications for sleeve 
resection (Lowe et al., 1982). These are often found in young patients in 
which salvage of functional lung tissue is important. A margin of resection 
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of 5 mm beyond the tumor is considered safe in these lesions (Pairolero et 
al., 1989). In case of an obstructing bronchial lesion laser therapy can be 
indicated to reduce tumor mass and to facilitate a subsequent bronchoplastic 
procedure. Indications for sleeve resection in carcinoid tumors and the 
possible role of preoperative laser therapy are discussed in more detail in 
chapter 8. 
In the case of a centrally located bronchogenic carcinoma, sleeve resection, 
if anatomically feasible, is indicated in patients with compromised 
pulmonary function precluding pneumonectomy. Apostoperative predicted 
FEV1 (forced expired volume in one second) of less than 1.0 liter indicates 
a greater likelihood of complications with pneumonectomy (Faber, 1987; 
Miller et al., 1987). Preservation of lung tissue is therefore of utmost 
importance in these patients. 
In squamous cell carcinoma, located at the orifice of a lobar bronchus, i.e. 
central, sleeve lobectomy is the operation of choice whenever technically 
possible (Faber, 1987). Second primary cancers are being detected with 
increasing frequency and patients who underwent sleeve resection might 
benefit from a subsequent resection which an initial pneumonectomy 
would have precluded [chapter 9]. 
The decision to carry out a sleeve resection for a bronchogenic carcinoma 
can be made preoperatively in which case careful bronchoscopic 
examination is mandatory to delineate the nature, site and macroscopic 
extent of the tumor. Biopsies at multiple proximal and distal levels are 
necessary to precisely judge the tumor extension and evaluate possible 
submucosal growth. Computed tomography (CT) of the chest is done 
routinely. It gives detailed information about tumor localization, extent and 
possible hilar and mediastinal involvement but provides no histologic 
diagnosis. At the Antonius Hospital, a cervical mediastinoscopy is routinely 
performed for preoperative mediastinal staging of bronchogenic carcinoma 
[chapter 4]. Nodes are sampled at the para- and pretracheal levels, the 
carina and tracheobronchial angle. Evaluation of tumoral peribronchial 
extension at this last level is possible to judge proximal invasion. 
The decision to perform a sleeve resection can be made intraoperatively 
when there is unexpected proximal extension in or around a main bronchus, 
or in case of a peripheral tumor, when metastatic hilar lymph nodes are 
present that invade a lobar bronchus at its junction with the main stem 
bronchus (Deslauriers et al., 1986; Faber, 1987). Frozen section biopsies 
of lobar, hilar and mediastinal lymph nodes should be performed during 
operation. Metastatic interlobar nodes in a major fissure generally 
contraindícate a sleeve procedure. Frozen section examination of the 
bronchial resection margins should also be obtained to judge adequate 
tumor clearance. For bronchogenic carcinoma a tumor-free margin of at 
least 1 cm should be present, proximally as well as distally (Kittle, 1989), 
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in contrast to a margin of 5 mm for tumors of low-grade malignancy 
(Pairolero et al., 1989). 
Sleeve resection should not be performed when there is severe suppuration 
distal to an obstructive tumor, in which case a pneumonectomy is indicated. 
When a proximal tumor also invades the pulmonary artery at the level of 
a lobar bronchus, it may be appropriate to accomplish a wedge or sleeve 
resection of the pulmonary artery together with a bronchial sleeve. When 
a full sleeve of the pulmonary artery is also performed this is called a 
"double sleeve" resection (Vogt-Moykopf et al., 1986). However, 
angioplastic operations in addition to bronchoplastic carry an increased 
morbidity. 
In general, sleeve resection is only indicated in a small but significant 
number of patients with lung carcinoma, representing 5 to 8% of all 
resections (Lowe et al., 1982). A controversial issue is the role of preoperative 
irradiation in patients with lung cancer who are considered candidates for 
sleeve lobectomy. It could decrease tumor volume, eliminate nodal 
metastases and hence downstage the tumor. However, Faber (1987) found 
no beneficial effect of preoperative irradiation on 5 and 10-year survival 
rate. In our series of sleeve resections no preoperative radiotherapy was 
given. 
6.2. Technique of bronchial sleeve resection 
Bronchial sleeve resection is usually performed through a posterolateral 
approach via the fourth or fifth interspace. When associated procedures are 
necessary or in case of severely restricted pulmonary function, a median 
sternotomy may be used for upper lobe sleeve resections although this is 
technically more demanding. 
Unilateral endobronchial anesthesia greatly facilitates the procedure and is 
accomplished by selective intubation of main bronchi using either a double 
lumen endotracheal tube or a very long tube which can be passed selectively 
into a main bronchus. The position of the tube is checked bronchoscopically. 
In some instances, high frequency ventilation has been used (McKinney et 
al., 1988; Nakatsuka et al., 1988). 
After the thorax has been entered a careful evaluation of the pathologic 
process is made. This requires some dissection of the hilar region, major 
and minor fissures. Special attention is given to the precize localization of 
the tumoral process and to any peribronchial extension or invasion of the 
pulmonary artery. In this way, judgment is made about the possibility of 
performing a sleeve resection and the necessity of an angioplastic procedure 
in addition to the bronchoplasty. In some instances a final decision can only 
be made after transection of the arteries and veins of the diseased lobe. 
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Interlobar, lobar, hilar and mediastinal nodes are sampled and frozen 
section examination is perfonned to determine any metastatic involvement 
and guide operative strategy. Tumoral extension across a major fissure or 
metastatic interlobar nodes in a major fissure generally contraindícate a 
sleeve resection (Faber, 1987). The involved bronchi are fully mobilized 
at the same time. 
The arterial and venous branches to the involved lobe or segment are 
transected and ligated. The bronchi are further mobilized and the proposed 
sites of transection are freed. Identifying sutures at the junction of the 
cartilaginous and membranous parts, proximally as well as distally, are 
helpful for proper orientation of the subsequent anastomosis. The main 
bronchi are incised in such a way as to obtain adequate tumor clearance. 
The bronchial blood supply is interrupted only at the line of division and 
the bronchus itself should not be "skeletonized", leaving as much of the 
peribronchial tissue as possible. 
Tumor extension determines the site of bronchial transection. In a right 
upper sleeve lobectomy, the proximal bronchotomy is always made close 
to the carina because of the short length of the right main bronchus, while 
distally, the bronchus is divided near its subdivisions (fig. 6.2.1 and 6.2.2). 
Figure 62.1. Right upper sleeve lobectomy. (From HurtR. Sleeve resection. In : 
JacksonJW.CooperDKC.RobandSmith'sOperariveSurgery.Thoracic 
Surgery. Fourth edition. Butterworths, London, 1986, p.170. Used by 
permission of Butterworth-Heinemann Limited.) 
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Figure 622. Right upper sleeve lobectomy. (From Hurt R. Sleeve resection. In : 
Jackson JW, Cooper DKC. Rob and Smith's Operative Surgery. Thoracic 
Surgery. Fourth edition. Butterworths, London, 1986,p.l70. Used by 
permission of Butterworth-Heinemann Limited.) 
A cylinder of main bronchus up to about 2.5 cm can be removed (Hurt, 
1986). In a left upper sleeve lobectomy, the proximal division is made 
farther from the carina because the left main stem bronchus is longer than 
the right one and has a close proximity to the aortic arch (fig. 6.2.3). After 
adequate mobilization, one can be more liberal in taking a larger piece of 
bronchus. 
Frozen section examination of the divided edges is routinely performed to 
rule out the presence of residual tumor cells. A tumor-free margin of at least 
1 cm should be obtained (Kittle, 1989), except for tumors of low-grade 
malignancy where a margin of 5 mm is acceptable (Pairolero et al., 1989). 
When the section margin is found to be positive an additional bronchial 
ring is removed whenever possible. 
Vascularization of the bronchial margins is checked. If they appear pale and 
do not bleed spontaneously, further resection is necessary. In case of an 
upper sleeve lobectomy the inferior pulmonary ligament can be divided. 
Pericardial release by incision of the pericardium in an arc beneath the 
inferior pulmonary vein allows additional hilar mobilization, if necessary 
(Mathisen et al., 1991). 
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Figure 623. Left upper sleeve lobectomy. (From Lowe JE, Bridgman AH, Sabiston 
DC. The role of bronchoplastic procedures in the surgical management 
of benign and malignant pulmonary lesions. J Thorac Cardiovasc Surg 
1982; 83:227-234. Used by permission of The C.V. Mosby Company.) 
After full mobilization of the remaining lobe or lobes, the bronchial 
anastomosis is constructed without tension in an end-to-end fashion. At 
present, in our series a single row of through-and-through interrupted 
polyglactin 3/0 (Vicryl®) sutures for the cartilaginous part and a continuous 
polypropylene 5/0 (Prolene®) suture for the membranous part of the 
anastomosis were mostly used. After the interrupted sutures for the 
cartilaginous part have been put in, these are tied, followed by suturing of 
the membranous part. Silk and teflon coated polyester sutures (Tevdek®) 
shouldnotbe used for bronchial anastomosis because of frequent granuloma 
formation and anastomotic narrowing. Other suture materials used are 
polyglyconate (Maxon®) or polydioxanone (PDS®), both resorbable but 
maintaining their tensile strength longer. As already proposed by Métras in 
1956, a submucosal suture can also be used. This is now performed with 
continuous polypropylene 4/0 (Prolene®). 
A difference in luminal size is mostly equalized by uneven spacing of 
sutures. As proposed by Thompson in 1964 excision of a longitudinal 
wedge from the larger bronchus can be helpful (fig. 6.2.4). Before final 
closure of the anastomosis the remaining lobe should be aspirated by a fine 
catheter. The anastomosis is tested for air leaks by submerging it in warm 
saline and gently inflating the lung. If necessary, additional sutures are 
placed. When a wedge excision or sleeve resection of the pulmonary artery 
has been performed the vascular anastomosis is made last with a continuous 
polypropylene 5/0 (Prolene®) suture. 
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Figure 62.4. Wedge resection of main bronchus to overcome discrepancy in size. 
(From Hurt R. Sleeve resection. In : Jackson JW, Cooper DKC. Rob and 
Smith's Operative Surgery. Thoracic Surgery. Fourth edition. 
Butterworths.London, 1986,p.l71. UsedbypermissionofButterworth-
Heinemann Limited.) 
To minimize the chance of a bronchopleural or bronchovascular fistula the 
bronchial anastomosis can be wrapped with a flap of pleura or pericardium 
although this is not uniformly applied. A vascular pedicle may augment the 
development of a systemic circulation across the anastomosis, although in 
one experimental study a pedicled pleural bronchial wrap did not 
significantly improve bronchial circulation (Ishihara et al., 1985). However, 
in a recent study of experimental lung autotransplantation in dogs, omental 
and intercostal muscle pedicle grafts promoted early bronchial 
revascularization. The superiority of an internal mammary artery pedicle 
graft to provide submucosal vascular ingrowth and to minimize anastomotic 
stenosis was demonstrated (Turrentine et al., 1990). 
At the end of operation, bronchoscopy is performed to check the anastomosis 
and aspirate secretions. Pleural drainage is accomplished routinely as after 
simple lobectomy. 
In left upper sleeve lobectomy a tape is placed around the left main 
pulmonary artery, which is retracted anteriorly, and the anastomosis is 
constructed preferentially posterior to the pulmonary artery. Since there is 
no bronchus intermedius on the left side, care should be taken not to divide 
the apical segmental bronchus while doing the distal bronchotomy. 
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In case of lower lobe sleeve resection, the remaining bronchus should be 
properly aligned to the main bronchus so as not to compromise the vascular 
supply and venous return to the remaining upper lobe. 
Wedge or partial sleeve resections are not advocated by most authors 
because of frequent postoperative kinking with secretion retention, 
atelectasis and pneumonia (Kittle, 1989; Vogt-Moykopf et al., 1986). 
6.3. Complications of bronchial sleeve resection 
In contrary to standard resectional procedures a bronchial anastomosis is 
created in sleeve resection which may give rise to particular complications 
not encountered after simple lobectomy or pneumonectomy. Most frequently 
reported is postoperative atelectasis requiring repeat bronchoscopy and 
endotracheal suctioning. Other complications specific to bronchial sleeve 
resection are granuloma formation (mostly encountered with the use of 
nonabsorbable braided polyester, silk or nylon), benign bronchial stenosis, 
necrosis of the anastomosis due to insufficient blood supply or local 
suppuration, bronchopleural and bronchovascular fistula, and local tumor 
recurrence.usually due to inadequate resection (Kittle, 1989). Complications 
of a vascular anastomosis include bleeding, thrombosis and bronchovascular 
fistula. Complications encountered in our series of sleeve resections are 
listed in chapter 7. 
Mostof these complications can be prevented by careful operative technique 
with frozen section examination of the bronchial margins and by creating 
a healthy bronchial anastomosis which is well vascularized. Interposition 
of a tissue flap between the suture line and the adjacent pulmonary artery 
is probably helpful in preventing a bronchovascular fistula, which is often 
lethal. 
Patients should be given proper postoperative care, including epidural 
analgesia and aggressive chest physiotherapy. When atelectasis is present, 
immediate bronchoscopy should be performed. 
In case of severe anastomotic problems or local recurrence, a completion 
pneumonectomy, during which the remaining lobe or lobes are removed, 
may eventually be required. Its incidence, indications and results in our 
series are discussed in chapter 10. 
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7.1. Abstract 
From 1960 to 1989,14Spatients(132menand 13 women) with a mean age 
of 60.3 years underwent sleeve lobectomy or sleeve resection of a main 
bronchus for a bronchogenic tumor. Squamous cell carcinoma was 
predominantly found (116 patients, 80.0%), followed by carcinoid tumor 
in 13 patients (9.0%). Postoperative staging was : Stage I, 61 patients 
(42.1%); Stage Π, 47 (32.4%); Stage ΠΙΑ, 33 (22.8%); Stage ШВ, 4 
(2.7%). 
Thirty-day mortality was 4.8% (7 patients). 
Follow-up was complete except for one patient who was lost to follow-up 
4 years after operation. For the whole group 5-, 10- and 15-year survival 
rates were 49%, 37% and 18% respectively. Better survival was noted in 
patients with carcinoid tumor and squamous cell carcinoma. Considering 
112 patients with T2 and T3 squamous cell carcinoma, 5- and 10-year 
survival rates for N0 disease (52 patients) were 59% and 47%, for N1 
disease (51 patients) 21% and 0% and for N2 disease (9 patients) 44% and 
0%. Differences between N1 and N2 disease were not statistically 
significant. 
Survival after sleeve resection is best for carcinoid tumors and squamous 
cell carcinoma with negative nodes. Presence of N1 or N2 disease 
significantly worsens prognosis, with no 10-year survivors and no difference 
between N1 and N2 status. 
7.2. Introduction 
Bronchoplastic procedures including sleeve lobectomy were initially 
introduced for patients whose pulmonary function was insufficient to 
tolerate pneumonectomy (Paulson et al., 1955). 
In more recent years, sleeve lobectomy has evolved as an alternative to 
pneumonectomy in carefully selected cases of bronchial carcinoma, 
especially for centrally located lesions (Namke, 1989; Ungar et al., 1981). 
In 1981 we reported the results of 50 patients with bronchial carcinoma 
who underwent right upper sleeve lobectomy (van den Bosch et al., 1981). 
In a subgroup of 22 patients with positive hilar lymph nodes no 5-year 
survival was found. In the present study long-term results were analyzed 
in 145 patients undergoing sleeve resection during the years 1960 to 1989. 
They represent our total experience with sleeve resection for bronchial 
tumors. Special attention was given to long-term survival in relation to 
lymph node involvement. 
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7.3. Material and methods 
7.3.1. Patient material 
During theyears 1960-1989,145patients, 132 men (91.0%) and 13 women 
(9.0%), underwent complete sleeve lobectomy or sleeve resection of a 
main bronchus. Wedge excisions or other bronchoplastic procedures e.g. 
bronchotomies, and sleeve pneumonectomies were excluded. Mean age 
was 60.3 ±11.8 years (range 22-80). 
Indications for sleeve resection were central localization of the tumor in 
122 patients (84.1%), presence of metastatic lymph nodes near a main 
bronchus in 4 patients (2.8%), and compromised pulmonary function 
precluding pneumonectomy in 19 patients (13.1%). 
Preoperatively, 128 patients (88.3%) underwent routinely cervical 
mediastinoscopy, 4 of which were repeat mediastinoscopies, which showed 
no metastatic mediastinal lymph nodes except in 2 patients who had limited 
ipsilateral intranodal disease. In 17 patients (11.7%) no preoperative 
cervical mediastinoscopy was performed. Most of these had carcinoid 
tumors. During operation hilar and mediastinal lymph nodes were routinely 
sampled in all patients. 
Procedures performed are listed in table 7.1. Sleeve resection of the right 
upper lobe was the most common procedure, performed in 117 patients 
(80.8%). Six patients (4.1%) underwent sleeve resection of a main 
bronchus without resection of pulmonary parenchyma. 
Table 7.1. Different types of sleeve resections 
Side 
Right 
Left 
Total 
Lobectomy 
Upper Lower 
117 2 
12 8 
129 10 
No Parenchyma 
Resected 
2 
4 
6 
Total 
121 
24 
145 
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Concomitant procedures on the pulmonary artery were wedge excision in 
4 patients, sleeve resection in 4 , and transection and reanastomosis to 
facilitate bronchial approach in 1 patient undergoing a sleeve resection of 
the right main bronchus. 
Histological diagnosis is given in table 7.2 ; squamous cell carcinoma 
(80.0%) and carcinoid (9.0%) were most frequently found. 
Table 72. Histology 
Histology No. % 
squamous cell carcinoma 
carcinoid 
adenosquamous carcinoma 
adenocarcinoma 
small cell carcinoma 
large cell undifferentiated 
adenocystic carcinoma 
sarcoma 
sarcoma (+ squamous cell carcinoma) 
combined tumor 
116 
13 
5 
4 
2 
80.0% 
9.0% 
3.4% 
2.7% 
1.4% 
0.7% 
0.7% 
0.7% 
0.7% 
0.7% 
All 145 patients were staged according to the most recent TNM classification 
(Mountain, 1987). Results of postoperative staging are shown in table 7.3. 
Table 73. Postoperative staging according to TNM classification 
(Mountain, 1987) 
Stage TNM status No. of patients 
Stage I 
Stage II 
Stage ША 
Stage ΙΠΒ 
T2N0M0 
Τ2Ν1Μ0 
T1N2M0 
T2N2M0 
T3N0M0 
T3N1M0 
T3N2M0 
T4N1M0 
T4N2M0 
61 
47 
33 
1 
11 
10 
8 
3 
4 
3 
1 
(42.1%) 
(32.4%) 
(22.8%) 
( 2.7%) 
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Patients with N1 disease were subdivided into N1 distal and N1 proximal 
disease, this last group including patients with metastatic lymph nodes 
between the upper lobe and main bronchus. 
Chemotherapy was given to the 2 patients with small cell carcinoma and 
radiotherapy was given to 20 patients (13.8%). Indications forradiotherapy 
were N2 disease and extranodal N1 disease; a positive resection margin 
was the indication for radiotherapy in 4 patients, and in another 1 radiotherapy 
was indicated for a T4 tumor involving the trachea. 
7.3.2. Methods 
Follow-up data were gathered from the files of the patients followed up in 
our institution, and for the others information was obtained from the 
referring pulmonary physicians by a questionnaire. 
Survival rates were calculated and analyzed using program IL of BMDP 
Statistical Software, hos Angeles, California (1990). Survival curves were 
obtained according to the Kaplan-Meier actuarial method. Survival 
between subgroups was compared with the generalized Savage (Mantel-
Cox) test or the trend from of the Tarone-Ware test. Chi-square test for 
rectangular contingency tables (with continuity correction where necessary) 
was used for comparing qualitative survival data. Relative risks were 
calculated according to Cox proportional hazards model. 
7.4. Results 
7.4.1. Operative mortality and complications 
Operative mortality was 4.8% (7 patients). One patient died during 
operation because of ventricular fibrillation. Six patients died 
postoperatively. Causes were bronchovascular fistula in 1 patient, sepsis in 
2, respiratory insufficiency in 2, and gastrointestinal bleeding in 1. 
Positive resection margins were present in 10 patients (6.9%), of whom 4 
were given radiotherapy, 3 underwent completion pneumonectomy within 
several weeks (before 1980), and 3 were given no specific treatment. 
Early postoperative complications could only be examined with certainty 
in the patients operated from 1980 on (n=92); these are listed in table 7.4, 
together with the late complications for all patients. There was no 
incidence of late bronchopleural or bronchovascular fistula. 
Ten of the 13 patients with bronchostenosis had completion 
pneumonectomy; the 3 others underwent bronchoscopic dilation. 
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Table 7.4. Early and late postoperative complications 
Early Postoperative Complications : 37.6% 
(92 patients from 1980) 
Air leakage (>3 days) 16 (17.4%) 
Atelectasis 
Respiratory insufficiency 
ARDS 
Empyema 
Gastrointestinal bleeding 
Anastomotic dehiscence 
9 ( 9.8%) 
4(4.3%) 
1 ( 1.1%) 
1 ( 1.1%) 
3(3.2%) 
1(1.1%) 
Late Postoperative Complications : 8.9% 
(all patients) 
Bronchostenosis 13 ( 8.9%) 
Local recurrence was observed in 26 patients (17.9%). Five of these 
underwent completion pneumonectomy (mean interval from operation, 
10.8 months; range 2 to 17 months), 19 died with local recurrence, 10 of 
whom had also metastatic disease (mean interval from operation, 42.9 
months; range 2 to 124 months), and 2 patients are still alive 29 and 39 
months after operation. 
7.4.2. Survival data 
Follow-up was complete for the 138 operative survivors except for 1 
patient who was lost to follow-up 4 years after operation. Mean follow-up 
was 47.9 months. Maximum follow-up was 223 months. 
All survival data include operative mortality. 
Actuarial survival for all 145 patients is depicted in figure 7.1. Median 
survival time was 58 months; 5-year survival rate, 0.49 ± 0.05; 10-year 
survival rate, 0.37 ± 0.05; and 15-year survival rate 0.18 ± 0.07. 
During follow-up 74 patients (51 %) died. Causes of death are listed in table 
7.5. Seventy-one patients (49%) are alive, 63 (43.4%) without evidence of 
disease. Two patients ( 1.4 %) are alive with local recurrence, 3 (2.1 %) with 
metastases, and 3 (2.1%) with another tumor. 
No difference in survival was observed between patients with compromised 
or noncompromised lung function (p=0.24). 
Survival was studied according to the histological type. For the 13 patients 
with carcinoid tumor the 15-year survival rate was 1.00, which shows the 
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Fig. 7.1 Actuarial survival curve with one standard deviation for the 145 patients 
undergoing sleeve resection. 
Table 75. Causes of death in 74 patients (51%) dying during follow-up* 
Cause No. % 
Operative mortality 
Local recurrence 
Metastases 
Local recurrence + metastases 
Cardiac 
Other 
Unknown 
7 
9 
25 
10 
11 
10 
2 
4.8% 
6.2% 
17.2% 
6.9% 
7.6% 
6.9% 
1.4% 
* Percentages are calculated for the whole group 
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clinically benign behavior of these tumors. The 5-year survival rate for the 
patients with adenocarcinoma and adenosquamous carcinoma (n=9) was 
0.25 ± 0.22. The actuarial survival curve for the 116 patients with 
squamous cell carcinoma is given in figure 7.2. Five-, 10-, and 15-year 
survival rates in this group were 0.46 ± 0.05,0.32 ± 0.06, and 0.13 ± 0.06, 
respectively. 
There was no difference in survival between left-sided or right-sided sleeve 
resections (p=0.89) and between sleeve resections of upper or lower lobes 
(p=0.77) in these patients. 
Actuarial Survival of 116 patients 
with squamous cell carcinoma 
proportion surviving 
Q I I I I I I I 1 1 1 1 
0 24 48 72 96 120 144 168 192 216 240 
Months 
Fig. 72 Actuarial survival curve with one standard deviation for the 116 patients 
with squamous cell carcinoma. 
Survival according to stage for the patients with squamous cell carcmoma 
is given in table 7.6. Stage I patients did significantly better than the others 
(p=0.01) but there was no difference between stage II, ША and ШВ (the 
number of patients in the last two groups was small). 
Survival according to lymph node involvement (fig.7.3) was calculated for 
112 patients with T2 and T3 squamous cell carcinoma. The results are 
given in table 7.7. There were no 10-year survivors in the patients with N1 
and N2 disease. There was a significant difference between patients with 
N0 disease and N1 or N2 disease (p=0.008) but no difference between N1 
and N2 disease (p=0.85). Subdividing the 51 patients with N1 disease into 
N1 proximalandNl distal disease (fig.7.4) showed no significant difference 
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Table 7.6. Survival rate according to stage for the patients with squamous cell 
carcinoma.0 
Stage 
Stage I 
Stage II 
Stage ША 
Stage 11Ш 
nb 
50 
45 
17 
4 
5-year 
0.59 ± 0.07 
0.22 ± 0.10 
0.42 ±0.14 
0.38 ± 0.29 
10-year 
0.47 ±0.08 
0.00 ±0.00 
0.21 ±0.16 
0.00 ± 0.00 
15-year 
0.15 ±0.09 
0.00 ±0.00 
0.21 ±0.16 
0.00 ±0.00 
a
 Survival rates are given with standard deviation. 
b Number of patients. 
Actuarial Survival of 112 pts ( T2 & T3 ) 
according to lymph node involvement 
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Fig. 7.3 Actuarial survival curves according to lymph node involvement for 112 
patients with T2 and T3 squamous cell carcinoma subdivided into NO, N1 
and N2. 
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Table 7.7. Survival rate according to lymph node involvementfor 112 patients with 
T2 and T3 squamous cell carcinomcfl. 
N 
NO 
N1 
N2 
nb 
52 
51 
9 
5-year 
0.59 ± 0.07 
0.21+0.09 
0.44 ±0.17 
10-year 
0.47 ± 0.08 
0.00 ±0.00 
0.00 ±0.00 
15-year 
0.19 ±0.08 
0.00 ±0.00 
0.00 ±0.00 
a
 Survival rates are given with standard deviation 
b Number of patients 
Actuarial Survival of 51 N1 pts 
( T2 and T3 ) squamous cell ca. 
proportion surviving 
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Fig. 7.4 Actuarial survival curves for the 51 N1 patients with T2 and T3 squamous 
cell carcinoma subdivided into N1 proximal and N1 distal disease. 
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in survival between these two groups (p=0.56). The relative risk related to 
mortality of N1 versus NO disease was 2.IS and of N2 versus NO disease 
2.35. 
Causes of death according to N category are given in table 7.8. Looking 
at the different N groups there was no significant difference in local 
recurrence rate (p>0.25). However, comparing distant metastases between 
NO disease and the two other groups, the difference reached statistical 
significance (0.01<p<0.025). 
Table 7.8. Causes of death according to N category in the 
patients with T2 and T3 squamous cell carcinoma. 
NO 
N1 
N2 
1 
3 
4 
0 
7 
2 
4 
3 
1 
8 
3 
5 
11 
1 
17 
4 
2 
4 
3 
9 
5 
7 
2 
1 
10 
6 
8 
2 
0 
10 
7 
1 
1 
0 
2 
30 
27 
6 
63 
1 : operative mortality 
2 : local recurrence 
3 : metastases 
4 : local recurrence + metastases 
5 : cardiac 
6 : other 
7 : unknown 
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7.5. Comment 
In 1952 Allison performed the first sleeve resection for a bronchogenic 
carcinoma although no details of the procedure were reported (Johnston et 
al., 1959; Kittle, 1989). After the report of Paulson and associates in 1970, 
describing 54 patients with bronchoplastic procedures, sleeve lobectomy 
gained wider acceptance as therapy for centrally located benign tumors and 
tumors of low-grade malignancy, and also for patients with bronchogenic 
carcinoma and limited pulmonary reserve who could not tolerate 
pneumonectomy (Lowe et al., 1982). 
Many authors (Ayabe et al., 1982; Belli et al., 1985; Bennett et al., 1978; 
Deslauriers et al., 1986; Faber, 1987; Finnin et al., 1983; Kittle, 1989; 
Lowe et al., 1982; Naruke, 1989; Ungar et al., 1981; Vogt-Moykopf et al, 
1986; Weisel et al., 1979) have reported their results with sleeve resection, 
and in more recent years it has been shown that sleeve lobectomy can be 
an alternative to pneumonectomy in carefully selected patients, even with 
good pulmonary function. Sleeve resection now offers both conservation 
of pulmonary function and enhanced resectability (Wright et al., 1990). 
The reimplanted lobe contributes significantly to the overall pulmonary 
function (Deslauriers et al., 1986). The results of sleeve lobectomy 
compare favorably to those of pneumonectomy (Firmin et al., 1983), and 
Faber concluded in 1987 that sleeve lobectomy should be the operation of 
choice whenever technically feasible. 
Naruke analyzed the results of several reports dealing with bronchoplastic 
procedures (1989). Operative mortality varied between 0% and 11.4%. 
The incidence of anastomotic strictures ranged between 0% and 17.0%, of 
bronchial fistula between 1% and 11.4%, and of local recurrence between 
2% and 51%. Our operative mortality and early and late complications are 
in accordance with these data. 
The relationship between long-term survival after sleeve resection and 
lymph node involvement remains controversial. 
In 1981 no 5-year survivors were found among patients with positive hilar 
lymph nodes (van den Bosch et al., 1981). Since then, numerous reports 
have been presented dealing with survival after bronchoplastic resection 
according to lymph node status. The most important are summarized in 
table 7.9. Five-year survival rate in patients with N1 disease ranges from 
0% to 60%. Different kinds of operations (wedge excision, sleeve 
resection, other bronchoplastic procedures) and different histologic types 
result in substantial heterogeneity in these papers. 
In 1983 Firmin and co-workers reported in detail the long-term survival 
after sleeve lobectomy for squamous cell carcinoma according to lymph 
node involvement. Five- and 10-year survival rates were 71 % and 49% for 
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Table 7.9. Survival after bronchoplastic resection according to lymph 
node status. 
First author 
van den Bosch 
Ayabe 
Finnin 
Belli 
Deslauriers 
Vogt-Moykopf 
Naruke 
Present studya 
Year 
1981 
1982 
1983 
1985 
1986 
1986 
1989 
1990 
Number 
of 
patients 
50 
34 
90 
19 
72 
248 
111 
112 
5-year 
survival 
N0 N1 
64 0 
30 
71 17 
50 
67 60 
37 30 
50 46 
59 21 
N2 
l ib 
10b 
0 
33 
44 
10-year 
survival 
N0 N1 N2 
49 10 
47 0 0 
a
 Only the patients with T2 and T3 squamous cell carcinoma 
are considered here. 
b Percentage for combined N1 and N2 patients 
patients with N0 disease (n=53), and 17% and 10% for N1 disease (n=23), 
respectively. 
In the present report, in a group of 112 patients with T2 and T3 squamous 
cell carcinoma, the 5 and 10-year survival rates for N0 disease (n=52) were 
59% and47%, and for N1 disease (n=51) 21 % and 0% respectively. These 
results are very similar. 
The N1 subgroup was divided into patients with proximal and distal N1 
involvement, but no statistically significant difference was observed. 
There was also no difference between N1 and N2 disease. Although the 
number of patients with N2 disease was rather small, these patients did not 
worse than those with N1 disease. A possible explanation could be that the 
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patients with N2 disease were given radiotherapy postoperatively. 
When analyzing late death, patients with N1 and N2 disease mainly died 
of metastatic disease in contrast to patients with NO disease. So, in this 
setting the question remains whether patients with N1 disease should be 
regarded as having systemic disease and be treated accordingly when 
experience with neoadjuvant therapy grows (Gralla, 1988; Wright et al., 
1990). 
In conclusion, survival after sleeve resection is best for carcinoid tumors 
and squamous cell carcinoma with negative nodes. Presence of N1 or N2 
disease significantly worsens prognosis with no 10-year survivors and no 
difference between N1 and N2 status. 
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8.1. Abstract 
In the period August 1974 - April 198913 patients, 6 men and 7 women with 
a mean age of 36.9 years, underwent a sleeve resection for a centrally 
located bronchial carcinoid tumor. Operations performed were : sleeve 
lobectomy of the right upper lobe 7; sleeve lobectomy of the left lower lobe 
1 ; sleeve resection of the right main bronchus 2; sleeve resection of the left 
main bronchus 3. Five patients underwent preoperative laser therapy 
(begun in 1986). Histological diagnosis was typical carcinoid in all cases. 
Staging was T2N0M0 (stage I) in 7 patients and T3N0M0 (stage ША) in 
6 patients. There was no perioperative mortality. During follow-up (mean 
74.6 months) there was no late mortality and good results were found in 12 
patients without signs of recurrence or bronchial stenosis. One patient 
underwent a completion pneumonectomy 16 months postoperatively 
because of anastomotic stricture without evidence of tumor recurrence. 
With centrally located bronchial carcinoid tumors sleeve resections are 
preferred to more extensive resections. The salvage of functional lung 
tissue in these generally young patients is important. The excellent short 
and long-term results substantiate this policy. 
8.2. Introduction 
Whether a bronchoplastic procedure is preferable to a more aggressive 
resection as pneumonectomy in the treatment of centrally located bronchial 
carcinoid tumors, remains controversial (Breederveld et al., 1989; Kittle, 
1989; Van Damme et al., 1989). In this report we describe our experience 
with 13 patients who underwent a sleeve resection for a bronchial carcinoid 
tumor. Long-term results of these lung sparing operations are discussed. 
8.3. Material and methods 
During the period August 1974-April 198913 patients, 6 men and 7 women 
with a mean age of 36.9 years underwent a sleeve resection for a centrally 
located bronchial carcinoid tumor. In these 13 patients a so-called full 
sleeve resection was performed with a bronchial end-to-end anastomosis. 
Wedge excisions and other bronchoplastic procedures were excluded. 
These 13 patients represent 14% of a group of 93 patients who were 
operated on for bronchial carcinoid tumors during the same period and they 
include all patients who underwent a sleeve resection. In total, 145 patients 
underwent a bronchial sleeve resection for a lung tumor of which the 13 
patients with a carcinoid tumor represent 9% (table 8.1). 
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Table 8.1. Number of sleeve resections and operations for bronchial 
carcinoid tumors. 
93 operations 
bronchial carcinoid tumors 
14% 
13 patients 
sleeve-carcinoid 
| 9% 
145 sleeve resections 
The group of 13 bronchial sleeve resections can be divided into 8 sleeve 
lobectomies and 5 sleeve resections of a main bronchus without excision 
of pulmonary parenchyma (fig.8.1 and 8.2). As indicated two patients 
underwent a sleeve resection of the right main bronchus. In one of them 
a right upper lobectomy was previously performed because of tuberculosis 
and in the other the right pulmonary artery was transected and later 
reanastomosed to facilitate bronchial approach and sleeve resection. 
In one patient who had a bilateral carcinoid tumor, a right lower lobectomy 
and a sleeve resection of the left main bronchus were performed by way of 
a right posterolateral thoracotomy. 
Diagnosis was typical carcinoid tumor in all cases. Five patients with an 
obstructing bronchial tumor were treated preoperatively by laser therapy 
to reduce tumor mass (from 1986 on). 
As suture material for the bronchial anastomosis in 10 patients interrupted 
polyglactin (Vicryl®) sutures were used for the cartilaginous part and 
continuous polypropylene (Prolene®) sutures for the membranous part, 
and in the 3 others the whole anastomosis was performed with continuous 
polypropylene (Prolene®). 
Follow-up data were gathered from the files of the patients followed in our 
institution and for the others information was obtained from the referring 
pulmonary physicians. 
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SLEEVE LOBECTOMY 
right upper lobe : 7 
left lower lobe : 1 
Figure 8.1 : Number of sleeve lobectomies 
SLEEVE MAIN BRONCHUS 
right main bronchus : 2 
left main bronchus : 3 
Figure 82 : Number of sleeve resections of a main bronchus without 
excision of pulmonary parenchyma 
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8.4. Results 
Operative mortality was 0%. There were also no major postoperative 
complications. 
The patient who was operated for a bilateral carcinoid tumor had a positive 
resection margin at the left main bronchus. Further resection was not 
possible technically. Postoperative radiotherapy was proposed to the 
referring pulmonary physician but was not given to the patient. 
Mean follow-up was 74.6 months (range 6-180). No patient died during 
this follow-up period. So, 10 and 15-year actuarial survival rates were 
100%. In 11 patients results were excellent without signs of recurrent 
tumor, distant metastases or complications of the bronchial anastomosis 
such as stenosis or fistula. One patient underwent a completion 
pneumonectomy 16 months postoperatively because of a severe stenosis of 
the bronchial anastomosis without recurrent tumor. In the patient with a 
positive resection margin no recurrence was noted 9 months postoperatively. 
From these data one can conclude that typical carcinoid tumors have 
clinically a benign course. 
8.5. Comment 
Bronchial carcinoid tumors were formerly called bronchial adenomas. 
However, this term induces confusion and is now replaced by three more 
specific entities : bronchial carcinoid tumor, adenoid cystic carcinoma and 
mucoepidennoid carcinoma of the trachea and bronchial tree (Tombeur et 
al., 1980). 
In bronchial carcinoid tumors cells are found that have the same 
characteristics as Kulchitsky's cells from the gastrointestinal mucosa 
(Paladugu et al., 1985). These cells arise from the primitive endoderm, 
undergo a neuroendocrine differentiation and are members of the APUD 
system. As there seems to be a neoplastic continuum between bronchial 
carcinoid tumors and small cell lung carcinoma, both originating from the 
bronchial Kulchitsky's cell, these are combined in one group named 
"Kulchitsky's cell carcinoma". This group is subdivided into three types : 
type I are the typical carcinoid tumors, type Π the atypical and type ΠΙ the 
undifferentiated small cell lung carcinomas (Paladugu et al., 1985; Wain et 
al., 1989). 
Type I, the typical carcinoid tumors are found in all age groups with an 
equal frequency in both sexes. Twenty-five percent occur as peripheral 
pulmonary nodules which are often asymptomatic, 75% are centrally 
located tumors which mostly give rise to symptoms when bronchial 
obstruction occurs. Cough, hemoptysis, dyspnea, wheezing and recurrent 
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bronchial infections are classic symptoms. 
Diagnosis is usually made bronchoscopically and bleeding after biopsy is 
a rare complication. In immunohistochemical stainings cytokeratins and 
neuroendocrine markers as chromogranins are found (Wain et al, 1989). 
The average doubling time is 45 to 120 months. Nodal metastases occur 
in only 4 to 11% of cases and distant metastases are almost never found. 
The carcinoid syndrome is present in less than 3% of patients. Five-year 
survival rate is 90 to 100%, which is excellent. 
Type II, the atypical carcinoid tumors, behave more as malignant tumors. 
They account for 10% of all bronchial carcinoid tumors. They are often 
larger than type I tumors and pathological characteristics include a more 
pronounced cellular pleomorphism and a higher mitotic activity. In 
contrary to type I tumors, cellular or tumor necrosis is present. The 
doubling time ranges from 6 to 20 months. Nodal metastases are found in 
46 to 70% of patients and distant metastases in 20%. Five-year survival 
rate is 55 to 70%. 
Type III, the small cell carcinomas are found as a sequela in 10% of patients 
with atypical carcinoid tumors. Treatment is mainly by polychemotherapy 
although surgery seems to be indicated in early stages (Shepherd et al., 
1991). 
There is a clear distinction between small cell lung carcinomas and 
carcinoid tumors. As indicated, small cell lung carcinomas are type ΠΙ of 
Kulchitsky's cell carcinoma without being part of the carcinoid tumors 
which include type I and type II. 
Treatment of typical and atypical carcinoid tumors is mainly surgical with 
special indications for bronchoplastic techniques (Kittle, 1989). The first 
bronchial wedge excision was performed in 1947 by Price Thomas for an 
obstructing carcinoid tumor at the right upper lobe orifice. Six years after 
operation result was excellent, although this case was only reported several 
years later (Thomas, 1954). 
In the ensuing years there was quite a lot of confusion and discussion about 
bronchial carcinoid tumors regarding their malignant nature and the best 
treatment : endoscopic resection or radical surgery. In 1949 Goldman 
stated that the malignant nature of bronchial carcinoid tumors was not so 
malignant but that their presumed benign course was not that benign. For 
this reason he advised radical surgery, i.e. lobectomy and pneumonectomy, 
as preferential treatment. 
In 1974 Jensik and colleagues demonstrated that more limited resections 
for bronchial carcinoid tumors can be performed successfully. In a series 
of 33 patients 70% could be treated by conservative resection, i.e. 
segmentectomy, bronchoplasty and sleeve lobectomy. 
Controversy still remains. In 1989 Breederveld and coworkers described 
a series of 23 patients in which 95% was treated by lobectomy and 
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pneumonectomy. They still advised radical surgery for bronchial carcinoid 
tumors, as was done by Van Damme et al.(1989). However, in the same 
year 1989, Kittle reported a series of 87 patients operated on for bronchial 
carcinoid tumors; 64% could be treated by conservative resection with 
excellent results. In our series of 13 patients who underwent a bronchial 
sleeve resection for a centrally located carcinoid tumor results were 
excellent after a mean follow-up of 6 years. For this group of patients with 
carcinoid tumor the only other surgical alternative was pneumonectomy. 
These are often young patients and the salvage of functional lung tissue 
offered by sleeve resection is a very important advantage. During operation 
frozen section examination of the bronchial resection margins is necessary 
to judge adequate tumor clearance. 
Another controversy which has recently been put forward is the role of 
laser therapy in patients with centrally located carcinoid tumors (Pairolero 
et al., 1989). Disadvantages of this technique are incomplete diagnosis by 
fulguration of tissue fragments, incomplete staging as lymph nodes are not 
accessible and incomplete excision as the deeper portions of the bronchial 
wall and an extrabronchial tumoral extent cannot be reached. 
When laser therapy is the sole form of treatment of these tumors, local 
recurrence occurs in 70% of cases (Maccaughan et al., 1985; Ricci, 1973). 
However, combination of laser and surgical treatment seems promising. 
After laser therapy, tumor mass has substantially been reduced which 
provides better insight in the precise localization of the tumor. In this way, 
a careful operative strategy can be planned which often makes conservative 
resection possible. 
In the case of an atypical carcinoid tumor, a more aggressive approach is 
necessary with an extensive hilar and mediastinal lymphadenectomy 
(Wain et al., 1989). 
The role of radiotherapy for carcinoid tumors remains unclear (Pairolero 
et al., 1989). 
Polychemotherapy is the main form of treatment for type ΙΠ small cell 
carcinomas although surgery may be indicated in early stages (Shepherd et 
al.,1991). Chemotherapy is indicated for type II tumors in case of distant 
metastases, although experience is limited (Grote et al., 1988). 
In conclusion, sleeve resections for centrally located bronchial carcinoid 
tumors, sometimes in association with laser therapy, are adequate operations 
with good long-term results. During the procedure frozen section 
examinations of the bronchial resection margins are necessary. In these 
generally young patients sleeve resections are preferable to more extensive 
procedures as pneumonectomy. The short and long-term results substantiate 
this policy. 
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9.1. Abstract 
During the years 1960-89 145 patients underwent sleeve lobectomy or 
sleeve resection of a main bronchus. Follow-up was complete except for 
one patient who was lost to follow-up 4 years after operation. Eleven 
patients (7.6%) developed a second primary cancer (SPC) in the lung, 10 
were men (90.9%). Mean age at sleeve operation was 61.2 ± 11.6 years. 
Mean interval between sleeve operation and development of SPC was 53.8 
months (range 6-197). All SPC occurred on the contralateral side. In 5 
cases there was squamous cell carcinoma, in 2 adenocarcinoma, in 1 
adenosquamous carcinoma, in 2 small cell carcinoma and in one patient no 
definite histology could be established. Different histology from the 
primary tumor was present in 5 patients. 
Seven patients (64%) were operated on : 5 underwent lobectomy and 2 
segmentectomy. In one patient the tumor was judged to be irresectable. 
Chemotherapy was given to the two patients with small cell carcinoma and 
radiotherapy to one patient presenting with bone metastases. 
Follow-up was complete for the eleven patients. Data were calculated from 
the moment of detection of SPC. There was one postoperative death due 
to myocardial infarction. Eight other patients died during follow-up : 5 of 
recurrent tumor or metastases, 2 of acute cardiac failure, 1 of perforated 
ulcer. One and 4-year actuarial survival rates were 41% and 30%. For the 
operated patients, 1 and 4-year survival rates were 57% and 43%. There 
were no 5-year survivors. 
Sleeve resection is a valuable method for preserving functional lung tissue 
offering a chance of subsequent resection in patients who develop SPC 
with acceptable results. 
9.2. Introduction 
Sleeve resection has been shown to be an adequate lung cancer operation 
and has evolved as an alternative to pneumonectomy in selected cases of 
bronchogenic carcinoma, especially for centrally located tumors. Even in 
patients with good pulmonary function sleeve resection is now frequently 
performed. It preserves functional lung tissue as the reimplanted lobe 
contributes significantly to overall lung function. 
The number of patients who develop a second primary lung cancer has been 
estimated to be 5% (Faber, 1987). These patients might benefit from a 
subsequent resection. In 145 patients undergoing sleeve resection for 
bronchial tumors we studied the incidence and subsequent treatment of 
metachronous second primary lung cancers. Survival rates were calculated 
according to the specific treatment given (operative versus nonoperative). 
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9.3. Patients and methods 
During the years 1960-89 145 patients underwent sleeve lobectomy or 
sleeve resection of a main bronchus. Follow-up was complete except for 
one patient who was lost to follow-up 4 years after operation. Eleven 
patients (7.6%) developed a metachronous second primary lung cancer. 
The criteria used for diagnosis were those of Martini and Melamed (1975): 
tumors of different histology (n=5) and tumors of same histological 
structure with (a) disease-free interval of at least 2 years (n=4) or (b) origin 
from carcinoma in situ (n=0) or (c) tumors in different lobe with no cancer 
in the common lymphatics or extrapulmonary metastases (n=2). 
The tumors were staged according to the new international staging system 
for lung cancer (Mountain, 1987). 
Actuarial survival curves were calculated according to the Kaplan-Meier 
method and difference in survival by the Mantel-Сох test using BMDP 
Statistical Software (Los Angeles, 1990). 
9.4. Results 
Of the 11 patients, 10 were men (90.9%). Mean age at sleeve operation was 
61.2 years (range 42-77). Characteristics at initial operation are given in 
table 9.1, those of the second primary tumor in table 9.2. Mean interval 
between sleeve operation and development of the second primary tumor 
was 53.8 months (range 6-197). All second primaries occurred on the 
contralateral side. Different histology from the primary tumor was present 
in 5 patients. In one patient (no. 10) cytological examination showed 
malignant cells but no definite histology could be established. 
Of the 11 patients, 7 (64%) were operated on : 5 underwent lobectomy and 
2 segmentectomy. In one patient the tumor was judged to be irresectable. 
Chemotherapy was given to the two patients with small cell carcinoma and 
radiotherapy to one patient presenting with bone metastases. 
There was one postoperative death (14.3%) due to myocardial infarction. 
There were no major postoperative complications. 
Follow-up was complete for the 11 patients. Survival data include 
operative mortality and were calculated from the moment of detection of 
the second primary unless otherwise stated. Mean follow-up for the 11 
patients was 16.6 months (range 1-54), for the 7 operated patients 23.0 
months (range 1 -54). Eight patients died during follow-up : 1 of recurrent 
tumor, 3 of metastases, 1 of recurrent tumor and metastases, 2 of acute 
myocardial infarction (one of whom had bone metastases) and 1 of 
perforated ulcer (with progression of small cell carcinoma). Mean interval 
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between diagnosis of the second primary cancer and death was 19.4 months 
(range 4-54). Two patients are alive at 4 and 23 months after diagnosis of 
the second primary, one with an irresectable tumor, one without evidence 
of disease. 
Table 9.1. Characteristics at initial sleeve operation. 
No 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Age 
47 
66 
56 
56 
51 
64 
67 
42 
77 
75 
72 
Sleeve 
operation 
RUL· 
RUL 
RUL 
RUL 
RUL 
LUL 
Τ,Τ,Τ, 
RUL 
RUL 
LUL 
RUL 
Histology 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
adenocar­
cinoma 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
Date 
9/78 
7/76 
9/71 
7/79 
11/72 
3/86 
9/88 
9/89 
1/89 
2/86 
7/86 
TNM 
T2N1MO 
T2NOMO 
T2NOMO 
T2NOMO 
T2NOMO 
T2NOMO 
T2N2MO 
T2N2MO 
T2N1MO 
T2N1MO 
T2NOMO 
Stage 
II 
I 
I 
I 
I 
I 
IIIA 
IIIA 
II 
II 
I 
RUL, right upper lobe ; LUL, left upper lobe ; LLL, left lower lobe ; 
ca., carcinoma 
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Table 92. Characteristics of second primary cancer. 
No 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Interval 
(months) 
43 
70 
128 
17 
197 
35 
16 
6 
18 
46 
16 
Location 
LUL 
UIL 
Τ,Τ,Τ, 
LLL 
left hilus 
RLL 
RLL 
LUL 
left main 
bronchus 
RML -t-bone 
metastases 
I.LL 
Histology 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
small cell 
ca. 
adenosqua-
mous ca. 
adenoca. 
squamous 
cell ca. 
squamous 
cell ca. 
none 
small cell 
ca. 
Treatment 
lobectomy 
segmentectomy 
lobectomy 
lobectomy 
chemotherapy 
lobectomy 
lobectomy 
segmentectomy 
none 
radiotherapy 
chemotherapy 
TNM 
T2N0M0 
T1N0M0 
T2NOMO 
T2N1M0 
TXN2M1 
T2N1M0 
T2NOMO 
TINIMO 
T3N0M0 
TXMXMI 
TxNxMO 
Stage 
I 
I 
I 
II 
extensive 
II 
I 
II 
IIIA 
IV 
limited 
Follow-up 
(months) 
54 
8 
51 
16 
4 
23 
1 
β 
4 
6 
8 
Outcome 
dead 
dead 
dead 
dead 
dead 
alive 
dead 
dead 
alive 
dead 
dead 
LUL, left upper lobe; LLL, left lower lobe; RML, right middle lobe; RLL; right lower lobe; ca.,carcinoma 
For the 11 patients, 1 and 4-year actuarial survival rates were 0.41 ± 0.16 
and 0.30 ±0.15 respectively. There were no 5-year survivors. 
For the 7 operated patients, 1 and 4-year survival rates were 0.57 ±0.19 and 
0.43 ± 0.19 respectively. There were no 1 -year survivors in the nonoperated 
patients (fig.9.1). However, the difference between operated and 
nonoperated patients was not statistically significant (p=0.10). 
Actuarial survival of patients with SPC 
from detection of SPC on 
V 
0.8 
0.6 
0.4 
0.2 
0 
Survival 
- Y\ 
\ \ 
1 
\ 
\ + " · •· 
^ 
e—ι 
4- - · 
ι 
— all patients 
—b- operated patients 
* nonoperated patients 
+ + 
\ 
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Figure 9.1. Actuarial survival curves for the 11 patients with a second primary 
cancer (SPC), for the 7 operated patients and for the 4 nonoperated 
patients from the moment of detection of the SPC on. 
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For the 11 patients, 5 and 10-year survival rates from the initial sleeve 
operation onward were 0.50 ± 0.16 and 0.25 ±0.15 (fig.9.2) and for the 7 
operated patients, 0.57 ± 0.19 and 0.19 ± 0.17 respectively. The difference 
between operated and nonoperated patients was not statistically significant 
(p=0.53). 
Actuarial survival of patients with SPC 
from sleeve operation on 
Survival 
1 
Figure 9.2. Actuarial survival curve with standard deviation for the II patients 
with a second primary cancer (SPC) from the initial sleeve operation 
onward. 
9.5. Comment 
Although bronchogenic carcinoma is the most common tumor in the 
western civilization and is potentially a multifocal disease, the incidence 
of multiple primary lung cancers, as a total of all bronchogenic carcinomas, 
is rather low and ranges from 0.5 to 3.9 percent (Song-chang et al., 1987). 
A higher percentage was found by van Bodegom and co-workers (1989) 
who diagnosed a second primary lung cancer in 10% of all patients with 
lung carcinoma. 
The reasons for this rather low incidence are probably the overall poor 
107 
prognosis for patients with bronchogenic carcinoma not allowmg them to 
develop a second primary tumor (Robinson et al., 1958), but also the 
inadequate recognition of this disease in the first place (Song-chang et al., 
1987). 
Precise criteria for diagnosis of a second primary cancer are difficult to 
establish (Jensik et al., 1981 ) and sometimes it is impossible to differentiate 
a second primary lesion from a metastasis or a local recurrence. The most 
widely used criteria are those of Martini and Melamed (1975) which 
include for metachronous tumors : tumors of different histology and 
tumors of same histological structure with (a) disease-free interval of at 
least 2 years or (b) origin from carcinoma in situ or (c) tumors in different 
lobe with no cancer in the common lymphatics or extrapulmonary 
metastases. 
Stricter criteria to define a second primary tumor were used by van 
Bodegom and colleagues (1989) : (1) different histological type from that 
of the first tumor, (2) location in a different lobe; (3) diagnosis at least three 
years after diagnosis of the first tumor. 
However, differentiation between a new primary tumor and a local recurrence 
or solitary metastasis regarding treatment might be not so important if the 
new lesion is resectable (Martini et al., 1975). 
The percentage of patients who develop a second primary cancer after an 
initial resection has been estimated to be 5% (Faber, 1987). Verflagen and 
co-workers (1989) found a percentage of 3.2% after resection for lung 
cancer. 
Second primary cancers can develop a long time after the initial operation 
(Reisher et al., 1991). In our group of 11 patients, 2 developed a new 
primary cancer more than 10 years after the initial procedure. This 
underscores the necessity of lifelong follow-up after resection for 
bronchogenic carcinoma. 
The need for initial conservative resections including sleeve operations, 
whenever possible, has been emphasized (Jensik et al., 1981). In a review 
article in 1987, Faber concluded that sleeve resection is a good alternative 
to pneumonectomy in selected cases of bronchogenic carcinoma and 
should be the operation of choice whenever technically feasible. It offers 
enhanced resectability, preservation of functional lung tissue (Wright et al., 
1990) and improved quality of life (Watanabe et al.,1990). 
Second primary cancers in the lung after sleeve resection and their 
management have infrequently been reported. In a series of 96 patients 
reported by Bennett and Smith in 1978, 3 developed a second primary 
bronchogenic carcinoma 6 to 8 years following sleeve resection. One of 
these lung lesions was resected, the two others treated by radiotherapy. 
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Weisel and co-workers (1979) reported a series of 70 patients who 
underwent sleeve lobectomy; 15 (11%) developed a second primary lung 
carcinoma but no details of subsequent treatment or outcome were given. 
In a series of 38 patients Robinson and colleagues (1981) reported one case 
of a second primary tumor 3 years after initial operation. This patient was 
given radiation therapy. Huidekoper and van Ginneken (1985) described 
43 patients who underwent sleeve resection for different types of bronchial 
tumors. The incidence of second primary bronchial carcinomas was 16% 
(7 patients), 4 of whom underwent lobectomy, one was given radiotherapy, 
one was treated by chemotherapy and one patient refused further treatment. 
Deslauriers and colleagues (1986) presented 72 patients who underwent 
sleeve lobectomy and reported 6 patients (8.3%) in whom a second primary 
cancer was diagnosed. Four patients could be treated by repeat resection 
including one second sleeve lobectomy. No precise survival data were 
given for these patients. In a series of 104 patients undergoing bronchoplastic 
procedures, Watanabe and co-workers (1990) described 2 patients with'a 
metachronous second primary cancer. One patient was treated by lobectomy, 
the otherby a second sleeve lobectomy without postoperative complications. 
Jensik and colleagues (1981) reported 64 patients with multiple primary 
bronchogenic carcinoma who underwent a second resective procedure. 
Four of these had undergone an initial sleeve lobectomy and developed a 
second primary cancer from 26 to 36 months after the first operation. Three 
were treated by segmentectomy and one by completion tracheal sleeve 
pneumonectomy. This last patient died postoperatively; two others died 1 
and 9 months after operation and one was alive at 15-year follow-up. 
In three recent articles patients with multiple primary lung cancers, none 
of whom had an initial sleeve resection, were discussed (Deschamps et al., 
1990; Fleisher et al., 1991; Verhagen et al., 1989). In a series of 1004 
patients with a resected lung cancer, 32 (3.2%) presented with a second 
primary tumor (Verhagen et al., 1989). A metachronous primary cancer 
was present in 25 (2.4%). Of this group, 22 patients underwent a second 
resection with three postoperative deaths. The 3 and 5-year actuarial 
survival rates for these patients were 43 and 31%. Very poor results were 
noted in the patients treated by irradiation and chemotherapy. 
In a report from the Mayo Clinic multiple primary lung cancers were 
diagnosed in 80patients,44 of whomhadmetachronous cancers (Deschamps 
et al., 1990). Operative mortality was 4.5%. In the patients with 
metachronous lung cancers overall 5 and 10-year survival rates for all 
stages afterpulmonary resection for the second carcinoma were 33.8% and 
27.0% respectively. In this series the overall incidence of multiple primary 
lung cancer was 1.2%. 
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Reisher and co-workers ( 1991 ) described 19 patients with multiple primary 
lung cancers. There was no operative mortality. Two and 5-year survival 
rates for the whole group were 53 and 32%, for the 9 operated patients 89 
and 61.6%. 
In our group of patients, who all had an initial sleeve operation, results 
yielded a higher operative mortality, that of 14.3%. The 2 and 5-year 
survival rates for the whole group were 30% and 0% and for the 7 operated 
patients 43% and 0% respectively. However, these results are acceptable 
if one considers that an initial pneumonectomy instead of a sleeve resection 
would have precluded a subsequent resection in these patients. Five and 
10-yearsurvival rates from the initial sleeve operation on forthe 11 patients 
with a second primary cancer were 50% and 25%, for the 7 operated 
patients 57% and 19% respectively. 
In conclusion, a second primary cancer was diagnosed in 7.6% of patients 
after initial sleeve resection. If feasible, surgery is the treatment of choice 
as is true for any second primary tumor. Initial conservative resections are 
important to preserve functional lung tissue. In this way, a chance of 
subsequent resection might be offered to patients who develop a second 
primary cancer. 
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10.1. Abstract 
During the years 1960-89,145 patients underwent sleeve lobectomy or 
sleeve resection of a main bronchus. 
Completion pneumonectomy (CP) was performed in 19 patients (13.1 %). 
Indications were bronchostenosis without malignancy in 10 patients, 
positive resection margins in 3, recurrent tumor in 5 and anastomotic 
dehiscence in 1. Mean age at sleeve operation was 59.3 years. In 18 
patients histology was squamous cell carcinoma and in one carcinoid 
tumor. Mean interval between sleeve resection and CP was 5.7 months 
(range 3-16) in the patients with stenosis and 6.6 months in the others 
(range 1-17). 
There were 3 postoperative deaths (15.8%). 
Mean follow-up was 53.2 months. Five and 10-year survival rates after CP 
for the patients with stenosis were 54% and 41 % and for the others 52% and 
52%, respectively. 
10.2. Introduction 
Sleeve resection has proven to be an adequate lung cancer operation and 
is an alternative to pneumonectomy in selected cases of bronchogenic 
carcinoma (Faber, 1987). It is a valuable method to preserve functional 
lung tissue and patients who develop a second primary cancer may benefit 
from a second resection. 
Contrary to standard resectional procedures, a bronchial end-to-end 
anastomosis is performed in full sleeve resection. This may cause 
anastomotic complications eventually necessitating completion 
pneumonectomy (Vogt-Moykopf etal., 1983), the incidence of which has 
infrequently been reported. In a series of 145 patients who underwent full 
bronchial sleeve resection the incidence and indications for completion 
pneumonectomy were studied. Mean follow-up after sleeve resection was 
47.9 months (maximum 223). ТЪе results and long-term survival according 
to the specific indication are discussed. 
10.3. Material and methods 
During the years 1960-89 145 patients underwent full bronchial sleeve 
lobectomy or sleeve resection of a main bronchus, which represents our 
total experience with bronchial sleeve resections. Follow-up was complete 
except for one patient who was lost to follow-up 4 years after operation. 
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Morbidity, mortality and long-term survival after sleeve resection were 
reported previously (Van Schil et al., 1991). 
In total, 19 patients (13.1%), all men, underwent completion 
pneumonectomy. Indications are listed in table 10.1. As late postoperative 
complication after sleeve resection a benign bronchostenosis was found in 
13 patients (8.9%). In 3 patients, bronchoscopic dilation was successful; 
in the 10 other, completion pneumonectomy was eventually performed. 
Three patients had positive resection margins at definitive pathological 
examination and underwent completion pneumonectomy within several 
weeks after the original sleeve resection and were all operated before 1980. 
Five patients had recurrent tumor (table 10.2) : 4 of them had negative 
Table 10.1. Indications for completion pneumonectomy (n=19) in a group of 145 
sleeve resections 
Indication 
benign bronchial stenosis 
recurrent tumor 
positive resection margins 
anastomotic dehiscence 
10 
5 
3 
1 
52.6 
26.3 
15.8 
5.3 
total 19 100 
Table 102. Characteristics of patients with recurrent tumor. 
NO 
1 
2 
3 
4 
5* 
initial 
TNM 
T2N1M0 
T2N0M0 
T2N1M0 
T2N1M0 
T2N0M0 
tumor 
Stage 
II 
I 
II 
II 
I 
histology 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
squamous 
cell ca. 
interval 
(months) 
2 
12 
17 
8 
15 
recurrent 
TNM 
T4N1M0 
T3N0M0 
T3N0M0 
T2N0M0 
T3NOM0 
tumor 
Stage 
HIB 
IIIA 
IIIA 
I 
IIIA 
* in this patient carcinoma in situ was found at the 
resection margin during sleeve operation 
carcinoma 
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resection margins and 1 carcinoma in situ at the initial operation (patient 
no.S). The one patient with anastomotic dehiscence underwent completion 
pneumonectomy 6 days after right upper sleeve lobectomy. During the 
original operation, purulent secretions were noted in the middle and lower 
lobes which were reimplanted. 
Mean age at sleeve operation was 59.3 ± 9.3 years (range 27-71). Sixteen 
patients had initially a sleeve resection of the right upper lobe, one a sleeve 
lobectomy of the right upper and middle lobes and two a left upper sleeve 
lobectomy. Histology showed squamous cell carcinoma in 18 patients and 
carcinoid tumor in one. 
Mean interval between sleeve operation and completion pneumonectomy 
was 5.7 months (range 3-16) in the patients with bronchostenosis and 6.6 
months (range 1-17) in the others. 
Follow-up data were obtained from the referring pulmonary physicians by 
a questionnaire or from the files of the patients followed in our institution. 
Actuarial survival curves were calculated according to the Kaplan-Meier 
method. Difference in survival was assessed by the Tarone-Ware testusing 
BMDP statistical software (Los Angeles, California 1990). Comparison 
between qualitative data was made with the Chi square test (with 
Yates'continuity correction when necessary). 
10.4. Results 
The main indication for completion pneumonectomy was stenosis of the 
bronchial anastomosis without recurrent tumor in 10 patients (table 10.1). 
In 4 of these, polypropylene (Prolene®) or teflon coated polyester 
(Tevdek®) was used as suture material and a continuous suture, interrupted 
and knotted at three places, 120 degrees apart, was performed. In the 6 
other patients, interrupted polyglactin (Vicryl®) sutures were used for the 
cartilaginous part and continuous polypropylene (Prolene®) for the 
membranous part of the anastomosis. 
In total, continuous polypropylene or teflon coated polyester was used in 
28 patients, mainly before 1980, giving an incidence of completion 
pneumonectomy for bronchostenosis in this group of 14.3%. In 105 sleeve 
resections, interrupted polyglactin sutures were used, with an incidence of 
completion pneumonectomy for bronchial stenosis of 5.7%. However, 
this difference was not statistically significant (p>0.25). 
Operative mortality of completion pneumonectomy was 15.8% (3 patients), 
2 due to cardiac causes (myocardial infarction and ventricular fibrillation), 
1 due to fistula of the bronchial stump, 4 days after completion 
pneumonectomy. 
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As major postoperative complication there was one other patient with a 
bronchopleural fístula treated by fenestration and secondary closure with 
omental transposition. This patient is doing well 9 months after completion 
pneumonectomy. 
All survival and follow-up data include operative mortality. Mean follow-
up after completion pneumonectomy for the 19 patients was 53.2 months. 
Maximum follow-up was 221 months. Six patients died during the follow-
up period. Mean interval between completion pneumonectomy and death 
was 39.8 months (range 3-105). Causes of death were local recurrence in 
one patient, distant metastases in two, cardiac cause in one, respiratory 
insufficiency in one and unknown in one patient. Ten patients are alive 
without signs of local recurrence or metastases after a mean follow-up of 
77.1 months (range 2-221). Fiveand 10-year survival rates after completion 
pneumonectomy for the 19 patients were 0.47 ± 0.14 and 0.38 ± 0.14 
respectively (fig. 10.1). For the 10 patients undergoing completion 
pneumonectomy because of bronchostenosis 5 and 10-year survival rates 
were 0.54 ± 0.14 and 0.41 ± 0.17; for the 9 others 0.52 ± 0.18 and 0.52 ± 
0.18 respectively (fig.10.2). The difference in survival between these two 
groups was not statistically significant (p=0.24). 
Actuarial survival of 19 patients with 
completion pneumonectomy 
survival rate 
1 
0 24 48 72 96 120 144 168 192 216 
months 
Figure 10.1 Actuarial survival curve with one standard deviation of the 19 patients 
who underwent completion pneumonectomy. 
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Actuarial survival curves according to 
the specific indication for CP 
survival rate 
1 
0 24 48 72 96 120 144 168 
months 
Figure 102. Actuarial survival curves of the 10 patients for whom indication was 
benign bronchostenosis and of the remaining 9 patients with other 
indications for completion pneumonectomy, listed in table 10.1 
(CP=Completion pneumonectomy). 
10.5. Comment 
In recent years bronchial sleeve resection has proven to be an adequate 
lung cancer operation and is an alternative to pneumonectomy in selected 
cases of bronchogenic carcinoma, mostly centrally located squamous cell 
carcinoma (Faber, 1987). Functional lung tissue is preserved which 
improves not only the quality of life (Watanabe et al., 1990) but may allow 
a subsequent resection in patients who develop a second primary lung 
cancer, the incidence of which has increased in recent years (Jensik et al., 
1981). 
However, in sleeve or wedge resections, a full or partial bronchial 
anastomosis is created which may cause additional complications not 
encountered in standard resectional procedures (Vogt-Moykopf et al., 
1983). Wedge or partial sleeve resections are not advocated by most 
authors because of frequent postoperative kinking with retention of 
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mucus, atelectasis and pneumonia (Kittle, 1989; Vogt-Moykopf et al., 
1986). In the so-called full sleeve resection a portion of the main bronchus 
is removed, followed by an end-to-end anastomosis of the remaining 
bronchial stump with the main bronchus. In this procedure the bronchial 
arteries are completely interrupted which may result in poor healing of the 
anastomosis. Creation of a tension-free anastomosis is of utmost importance. 
In an experimental model in dogs of lung reimplantation with complete 
interraption of the bronchial arteries, a network of many fine arterial 
channels across the anastomosis could be demonstrated by selective 
bronchial arteriography within 3 weeks of reimplantation. Reestablishment 
of distal bronchial arterial flow occurred within 4 weeks of bronchial artery 
division (Pearson et al., 1970). 
Whether covering of the bronchial anastomosis with some viable tissue to 
reduce ischemic complications after sleeve resection is necessary, remains 
controversial (Keszler, 1986). In dogs a pedicled pleural wrap did not 
significantly improve bronchial circulation (Ishihara et al., 1985). 
As most sleeve resections are performed for centrally located bronchial 
tumors, residual malignant cells at the suture line can give rise to early 
recurrence. This underscores the necessity of careful frozen section 
examinations of the bronchial margins before the anastomosis is made 
(Keszler, 1986). 
These anastomotic complications after sleeve resection can eventually 
result in completion pneumonectomy, the incidence of which has 
infrequently been reported. 
In a series of 43 patients who underwent sleeve resections for different 
types of bronchial tumors. Huidekoper and co-workers (1985) mentioned 
2 patients with late complications, one of which was a bronchial stenosis 
requiring completion pneumonectomy. 
Faber and Jensik described their experience with 118 sleeve lobectomies 
(Faber, 1987 ; Jensik et al., 1986) : completion pneumectomy was performed 
in 8 patients (6.7%) without operative mortality. Indications were mainly 
anastomotic complications, i.e. stenosis and dehiscence, in 6 patients, 4 of 
whom had received preoperative radiotherapy. In one patient indication 
for completion pneumonectomy was residual tumor at the resection 
margin and in another one recurrent tumor 16 months after sleeve lobectomy. 
In a series of 76 bronchoplastic procedures for bronchogenic carcinoma 
without carinal involvement Watanabe and colleagues (1990) described 
one patient in whom completion pneumonectomy was performed because 
of thrombosis of the pulmonary artery after left upper sleeve lobectomy 
with sleeve resection of the pulmonary artery, a so-called double sleeve 
resection. 
In our series of 145 patients who underwent full bronchial sleeve resection 
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completion pneumonectomy was necessary inl9(13.1%), none of whom 
had received preoperative radiotherapy. Main indications were benign 
bronchostenosis and local recurrent tumor. Five and 10-year survival rates 
after completion pneumonectomy were 47% and 38% with no difference 
in survival according to the specific indication for completion 
pneumonectomy. 
Mean interval between sleeve resection and completion pneumonectomy 
was relatively short, being 5.7 months in the patients with stenosis and 6.6 
months in the others. 
Regarding suture material for the bronchial anastomosis, in growing 
puppies absorbable suture was found to be superior to nonabsorbable 
suture (Hsieh et al., 1988). Also in humans absorbable sutures are mostly 
used (Deslauriers et al., 1986;Keszler, 1986; Watanabeet al., 1990). In our 
series the incidence of bronchial stenosis necessitating completion 
pneumonectomy was 14.3% when nonabsorbable polypropylene or teflon 
coated polyester was used as suture material, whereas the incidence was 
5.7% when absorbable polyglactin was used. However, this difference was 
not statistically significant. 
After sleeve resection, repeated bronchoscopy is necessary to aspirate 
secretions, remove granulation tissue and take biopsies in the region of the 
anastomosis when suspicious tissue is found. In case of stenosis of the 
bronchial anastomosis without recurrent tumor, bronchoscopic dilation is 
attempted. If this is not successful and persistent problems of atelectasis, 
infection or suppuration of the remaining lobe or lobes exist, a completion 
pneumonectomy is eventually performed. 
In a recent report 113 patients were described who underwent completion 
pneumonectomy after various operations, but none had an initial sleeve 
resection (McGovem et al., 1988). Overall operative mortality was 12.4%. 
Patients were divided in 3 groups according to the specific indication for 
completion pneumonectomy. In 64 patients indication was lung cancer. 
Operative mortality in this group was 9.4% with a 5-year survival rate of 
26.4%. TWenty patients were reoperated because of pulmonary metastases 
without operative mortality and a 5-year survival rate of 40.8%. In 29 
patients, the indication was a benign condition, including 3 patients with 
bronchial stenosis. In this last group operative mortality was 27.6% with 
55.2% having major complications related to an extensive inflammatory 
process found during operation; 5-year survival rate was 27.2%. 
In our series of 19 patients overall operative mortality was 15.8%. In 10 
patients (52.6%) indication for completion pneumonectomy was benign 
bronchostenosis. In this group one died postoperatively because of cardiac 
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arrhythmia and ventricular fibrillation giving an operative mortality of 
10% for benign conditions. 
Deslauriers (1988) pointed out that completion pneumonectomy is a 
technically difficult procedure that must be done by an experienced 
surgeon. As much as possible the intrapleural plane should be followed 
during dissection. When the intrapericardial cavity is not obliterated by 
previous radiotherapy or inflammation, intrapericardial vascular control is 
most often helpful. Reinforcement of the bronchial stump with viable 
tissue should be attempted to minimize postoperative stump complications. 
In conclusion, in our series of 145 patients who underwent sleeve resection, 
completion pneumonectomy was necessary in 19(13.1%). Frozen section 
examination of the bronchial resection margins during sleeve operation is 
mandatory to obtain adequate tumor clearance. After sleeve resection, 
regular bronchoscopic control is necessary to detect early recurrent tumor 
or anastomotic complications and treat accordingly. 
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11.1. Summary and conclusions 
Lung cancer remains a leading cause of death in our civilization. When the 
tumor is judged to be resectable, surgical extirpation is the treatment of 
choice. 
Accurate preoperative staging according to the TNM classification is of 
utmost importance to optimize treatment and to get insight into the 
prognosis. There is much debate about the value of mediastinoscopy in 
preoperative staging of bronchogenic carcinoma. To determine its role 
more precisely, the results of mediastinoscopy and computed tomographic 
scanning in 85 patients were compared with the findings at thoracotomy. 
Mediastinoscopy was performed in 48 patients when mediastinal nodes 
larger than 1 cm were found at computed tomographic scanning. Only 21 
of them (44%) were found to have metastatic nodes. Of the remaining 
patients, 22 were operated on and two showed false negative results (9%). 
Mediastinoscopy had a sensitivity of 91 % and a specificity of 100%. The 
positive predictive value of computed tomographic scanning was only 
54%. Thirty-seven patients underwent thoracotomy after having negative 
computed tomographic scan results. Eleven of them (30%) were found to 
have metastatic mediastinal lymph nodes. The negative predictive value of 
computed tomographic scanning was 70%. When results from both series 
of patients were compared, the sensitivity and specificity of computed 
tomographic scanning proved to be 68% and 57%, respectively, with an 
accuracy of 61%. 
At the Antonius Hospital, Nieuwegein, routine cervical mediastinoscopy 
is performed for precise mediastinal staging. At the University Hospital of 
Antwerp a more selective approach is used. Cervical mediastinoscopy is 
always performed in patients with centrally located tumors but not in case 
of a peripheral squamous cell carcinoma or an undiagnosed nodule smaller 
than 3 cm with negative nodes on CT scanning. 
In central leftupperlobe tumors anteriormediastinoscopy ormediastinotomy 
is recommended in addition to cervical mediastinoscopy to identify 
metastatic disease in the periaortic and subaortic lymph nodes. 
To judge operability of left-sided centrally located tumors the pericardium 
can be opened during anterior mediastinotomy to determine whether or not 
an intrapericardial pneumonectomy is feasible. 
During a 3-year period this procedure was performed in 11 patients. In 3 
(27.3%) extensive intrapericardial involvement precluded complete 
resection. Intrapericardial extension without complete invasion of the 
pulmonary vessels was present in 2 patients (18.2%) who subsequently 
underwent an intrapericardial pneumonectomy. In 6 patients (54.5%) no 
intrapericardial tumor was present. 
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There was no perioperative mortality. One patient underwent redrainage of 
the pleural cavity because of postoperative pneumothorax. 
In total, 4 patients (36.4%) underwent intrapericardial pneumonectomy, 6 
(54.5%) were treated by radiotherapy and one (9.1%) by chemotherapy. 
Thus, anterior mediastmotomy with opening of the pericardium yields 
additional information about the degree of tumor invasion and in this way 
unnecessary thoracotomies are avoided. 
In this thesis the short and long-term results of full bronchial sleeve 
resections performed for bronchogenic tumors at the Antonius Hospital 
were studied. These include sleeve lobectomies and sleeve resections of a 
main bronchus, in which a circumferential part of the bronchus is removed 
followed by an end-to-end anastomosis. 
From 1960 to 1989,145 patients, 132 men and 13 women, with a mean age 
of 60.3 years, underwent a full bronchial sleeve resection. Squamous cell 
carcinoma was the predominant finding (116 patients, 80.0%), followed by 
carcinoid tumor in 13 patients (9.0%). Postoperative staging was : Stage I 
61 patients (42.1 %), Stage II47 (32.4%), Stage ША 33 (22.8%), Stage ΙΠΒ 
4 (2.7%). 
Operative mortality was 4.8% (7 patients). 
Early postoperative complications were mainly respiratory : air leakage, 
atelectasis and respiratory insufficiency. 
Follow-up was complete in all patients except for one who was lost to 
follow-up 4 years after operation. Benign bronchostenosis developed in 13 
patients (8.9%). Ten of these underwent completion pneumonectomy and 
the remaining three underwent bronchoscopic dilation. 
Local recurrence was observed in 26 patients (17.9%). Five of these 
underwent completion pneumonectomy, 19 died with local recurrence, 10 
of whom also had metastatic disease and 2 patients are still alive. 
For the whole group 5,10 and 15-year survival rates were 49%, 37% and 
18% respectively. 
In the case of 112 patients with T2 and T3 squamous cell carcinoma, 5 and 
10-year survival rates were 59% and 47% for N0 disease (52 patients), 21 % 
and 0% for N1 disease (51 patients), and 44% and 0% for N2 disease (9 
patients). Differences between N1 and N2 disease were not statistically 
significant. 
Looking at the cause of death according to N category, there was no 
significant difference in local recurrence rate between N0 and combined 
N1 and N2 disease. However, looking at distant metastases as a cause of 
death the difference did reach statistical significance. 
Thirteen patients underwent a sleeve resection for a centrally located 
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bronchial carcinoid tumor. Operations performed were : sleeve lobectomy 
of the right upper lobe 7; sleeve lobectomy of the left lower lobe 1 ; sleeve 
resection of the right main bronchus 2; sleeve resection of the left main 
bronchus 3. Five patients underwent preoperative laser therapy (begun in 
1986). Histological diagnosis was typical carcinoid in all cases. Staging 
was T2N0M0 (stage I) in 7 patients and T3N0M0 (stage ША) in 6 patients. 
There was no perioperative mortality. During follow-up (mean 74.6 
months) good results were found in 12 patients, showing no late mortality 
or signs of recurrence or bronchial stenosis. One patient underwent a 
completion pneumonectomy 16 months postoperatively because of 
anastomotic stricture without evidence of tumor recurrence. 
The important advantage of a sleeve resection is the salvage of functional 
lung tissue in these generally young patients. 
During the follow-up period eleven patients (7.6%), 10 of which were men 
(90.9%), developed a second primary cancer in the lung. Mean age at 
sleeve operation was 61.2 ± 11.6 years. Mean interval between sleeve 
operation and development of the second primary tumor was 53.8 months 
(range 6-197). All second primaries occurred on the contralateral side. In 
5 cases there was squamous cell carcinoma; in 2, adenocarcinoma; in 1, 
adenosquamous carcinoma; in 2, small cell carcinoma and in one patient 
no definite histology. Different histology from the primary tumor was 
present in S patients. 
Seven of these patients with secondaries (64%) were operated on : 5 
underwent lobectomy and 2 segmentectomy. In one patient the tumor was 
judged to be irresectable. Chemotherapy was given to the two patients with 
small cell carcinoma and radiotherapy to one patient presenting with bone 
metastases. 
Follow-up was complete for the eleven patients. Data were calculated from 
the moment of detection of the second primary tumor. There was one 
postoperative death due to myocardial infarction. Eight other patients died 
during follow-up : 5 of recurrent tumor or metastases, 2 of acute cardiac 
failure, and 1 of perforated ulcer. One and 4-year actuarial survival rates 
were 41% and 30%. For the operated patients, 1 and 4-year survival rates 
were 57% and 43%. There were no 5-year survivors. 
Completion pneumonectomy was necessary in 19 patients (13.1%). 
Indications were bronchostenosis without malignancy in 10 patients, 
positive resection margins in 3, recurrent tumor in 5 and anastomotic 
dehiscence in 1. Mean age at sleeve operation was 59.3 years. In 18 patients 
histology was squamous cell carcinoma and in one carcinoid tumor. Mean 
interval between sleeve resection and completion pneumonectomy was 5.7 
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months (range 3-16) in the patients with stenosis and 6.6 months in the 
remaining (range 1-17). 
There were 3 postoperative deaths (15.8%). 
Mean follow-up was 53.2 months. Five and 10-year survival rates after 
completion pneumonectomy for the patients with stenosis were 54% and 
41% and for the others 52% and 52%, respectively. 
Conclusions : 
1. Accurate preoperative staging of the mediastinum in bronchogenic 
carcinoma still requires cervical mediastinoscopy, which should be 
routinely performed. 
2. In left-sided centrally located tumors the pericardium must be opened 
during anterior mediastinotomy to determine whether or not an 
intrapericardial pneumonectomy is feasible. 
3. Survival after bronchial sleeve resection is best for carcinoid tumors 
and squamous cell carcinoma with negative lymph nodes. Presence of 
N1 or N2 disease significantly worsens prognosis with no 10-year 
survivors and no difference between N1 and N2 status. 
4. There is a significant difference between NO and combined N1 and N2 
disease when looking at distant metastases as a cause of death after 
bronchial sleeve resection, but not when looking at the local recurrence 
rate. 
5. With centrally located bronchial carcinoid tumors, sleeve resections, 
sometimes in combination with preoperative laser therapy, are preferred 
to resections involving more parenchyma. 
6. Sleeve resection is a valuable method for preserving functional lung 
tissue, offering a chance of subsequent resection in patients who 
develop a second primary lung cancer. 
7. Although operative mortality of completion pneumonectomy after 
bronchial sleeve resection is high, long-term survival is good, 
irrespective of the indication for the operation. 
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11.2. Samenvatting en conclusies 
Bronchiale sleeve resecties : resultaten op lange termijn. 
BronchusCarcinoom blijft een belangrijke doodsoorzaak in onze 
samenleving. Wanneer de tumor te reseceren lijkt, geniet chirurgische 
therapie de vooikeur. Een nauwkeurige preoperatieve stagering volgens de 
huidige TNM klassificatie is uitermate belangrijk om een optimale 
behandeling in te stellen en inzicht te krijgen in de uiteindelijke prognose. 
Er is heel wat discussie over de precieze rol van mediastinoscopie in de 
preoperatieve stagering van het bronchuscarcinoom. 
Om meer nauwkeurig de waarde ervan te bepalen werden de resultaten van 
mediastinoscopie en CT scan bij 85 patiënten vergeleken met de gegevens 
veikregen bij thoracotomie. Een cervicale mediastinoscopie werd uitgevoerd 
bij 48 patiënten wanneer er mediastinale lymfeklieren met een diameter 
van 1 cm of meer op CT scan gevonden werden. 
In deze groep waren er slechts bij 21 patiënten (44%) metastatische 
mediastinale lymfeklieren aanwezig. 
Van de overige patiënten werden er 22 geopereerd met twee fout negatieve 
resultaten (9%). Mediastinoscopie had een sensitiviteit van 91% en een 
specificiteit van 100%. De positieve predictieve waarde van CT scan 
bedroeg slechts 54%. Zevenendertig patiënten met een negatieve CT scan 
ondergingen een thoracotomie. In deze groep werden bij 11 patiënten 
(30%) metastatische mediastinale lymfeklieren aangetroffen. De negatieve 
predictieve waarde van CT scan was 70%. 
Wanneer de resultaten van de 2 groepen met elkaar vergeleken werden 
bedroegen de sensitiviteit en specificiteit van CT scan 68 en 57% met een 
nauwkeurigheid van 61%. 
In het Antonius Ziekenhuis te Nieuwegein wordt routinematig een cervicale 
mediastinoscopie uitgevoerd om een nauwkeurige stagering van het 
mediastinum te verkrijgen. In het Universitair Ziekenhuis Antwerpen 
wordt een meer selectieve houding aangenomen. Een cervicale 
mediastinoscopie wordt uitgevoerd bij elke centraal gelegen tumor. In 
geval van een perifeer gelegen spinocellulair carcinoom of een nodule 
kleiner dan 3 cm. zonder histologische diagnose, wordt er geen 
mediastinoscopie verricht indien er geen positieve klieren op CT scan 
aanwezig zijn. 
Bij centraal gelegen tumoren van de linker bovenkwab wordt, naast een 
cervicale mediastinoscopie, eveneens een antérieure mediastinoscopie of 
mediastinotomie aangeraden om metastatische peri- en subaortische 
lymfeklieren op te sporen. 
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Om de operabiliteit van centraal gelegen tumoren aan de linker zijde beter 
te beoordelen kan tijdens een antérieure mediastinotomie het pericard 
geopend worden om te beslissen of een intrapericardiale pneumonectomie 
mogelijk is. Dit werd uitgevoerd bij 11 patiënten gedurende een periode 
van 3 jaar. 
Bij 3 patiënten (27,3%) was er een uitgebreide intrapericardiale invasie die 
een volledige resectie onmogelijk maakte. Een intrapericardiale uitbreiding 
zonder volledige invasie van de pulmonale vaten werd aangetroffen bij 2 
patiënten (18,2%) die vervolgens een intrapericardiale pneumonectomie 
ondergingen. Bij 6 patiënten (54,5%) werd er geen tumor intrapericardiaal 
aangetroffen. 
Er was geen perioperatieve mortaliteit. Omwille van een postoperative 
pneumothorax was een redrainage van de pleuraholte noodzakelijk bij één 
patiënt. In totaal werd bij 4 patiënten (36,4%) een intrapericardiale 
pneumonectomie uitgevoerd, 6 (54,5%) werden behandeld met 
radiotherapie en 1 (9,1%) met chemotherapie. 
Op deze manier verschaft openen van het pericard bijkomende informatie 
over de tumorale invasie intrapericardiaal en worden onnodige 
thoracotomies vermeden. 
In dit proefschrift werden de resultaten op korte en lange termijn bestudeerd 
van bronchiale sleeve resecties uitgevoerd voor bronchiale tumoren in het 
Antonius Ziekenhuis. Hierin zijn sleeve lobectomies en sleeve resecties 
van een hoofdbronchus begrepen waarbij een cylindrisch deel van een 
bronchus wordt weggenomen gevolgd door een end-to-end anastomose. 
In de periode 1960-1989 werd een bronchiale sleeve resectie uitgevoerd bij 
145 patiënten, 132 mannen en 13 vrouwen met een gemiddelde leeftijd van 
60,3 jaar. 
In de meerderheid der gevallen werd er een spinocellulair carcinoom 
aangetroffen (116patiënten; 80,0%), gevolgd dooreen typische carcinoid 
tumor bij 13 patiënten (9,0%). Postoperatieve stagering gaf 61 patiënten 
(42,1 %) in stadium 1,47 (32,4%) in stadium II, 33 (22,8%) in stadium ΠΙΑ 
en 4 (2,7%) in stadium ШВ. 
De operatieve mortaliteitbedroeg4,8% (7 patiënten). Vroege postoperatieve 
complicaties waren hoofdzakelijk respiratoir van aard : langdurige luchtlek, 
atelectase en respiratoire insufficiëntie. 
Follow-up was volledig behalve voor één patiënt die 4 jaar na de ingreep 
uit het oog verloren werd. 
Een goedaardige bronchiale sténose trad op t.h.v. de anastomose op bij 13 
patiënten (8,9%). Bij 10 werd een restpneumonectomie uitgevoerd, de 3 
overige werden behandeld met een bronchoscopische dilatatie. 
Tijdens de follow-up werd er een lokaal recidief aangetroffen bij 26 
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patiënten (17,9%). Vijf patiënten ondergingen een restpneumonectomie, 
19 zijn overleden met lokaal recidief waarbij er 10 eveneens metastasen op 
afstand hadden, en 2 patiënten zijn in leven met een lokaal recidief. 
De aktuariële overleving voor de ganse reeks was 49% na 5 jaar, 37% na 
10 jaar en 18% na 15 jaar. Wanneer we de 112 patiënten met een T2 en T3 
spinocellulair carcinoom in beschouwing nemen, bedroeg de overleving 
na 5 en 10 jaar voor de 52 patiënten in kategone N0 59 en 47%, voor de 51 
patiënten in kategone N121 en 0% en voor de 9 patiënten in kategorie N2 
44 en 0% respectievelijk. Er was geen significant verschil tussen kategorie 
N1 en N2. 
Wanneer we de doodsoorzaak bekijken in functie van het klierstadium was 
er geen significant verschil in lokaal recidief tussen de groep N0 van de ene 
kant en N1 en N2 gecombineerd van de andere kant. Als we echter kijken 
naar metastasen op afstand als doodsoorzaak werd het verschil statistisch 
significant. 
Bij 13 patiënten werd een bronchiale sleeve resectie uitgevoerd wegens 
een centraal gelegen bronchiale carcinoid tumor. De uitgevoerde ingrepen 
waren : sleeve lobectomie van de rechter bovenkwab in 7 gevallen, sleeve 
lobectomie van de linker onderkwab in 1, sleeve resectie van de rechter 
hoofdbronchus in 2 en van de linker hoofdbronchus in 3 gevallen. 
Vijf patiënten ondergingen preoperatief lasertherapie (na 1986). De 
histologische diagnose was in alle gevallen typisch carcinoid. De 
postoperatieve stagering was T2N0M0 (stadium I) bij 7 patiënten en 
T3N0M0 (stadium IIIA) bij 6 patiënten. 
Er was geen perioperatieve mortaliteit. Follow-up gegevens (gemiddeld 
74,6 maanden) toonden geen late mortaliteit en goede resultaten bij 12 
patiënten zonder tekens van recidief of bronchusstenose. Eén patiënt 
onderging 16 maanden postoperatief een restpneumonectomie wegens het 
bestaan van een sténose t.h.v. de anastomose zonder recidief tumor. 
Het behoud van funktioneel longweefsel dat een sleeve resectie biedt bij 
deze over 't algemeen jonge patiënten is erg belangrijk. 
Tijdens de follow-up periode werd bij 11 patiënten (7,6%) waarvan 10 
mannen (90,9%), een tweede primaire longtumor vastgesteld. 
De gemiddelde leeftijd bij de sleeve resectie was 61,2 ± 11,6 jaar. Het 
gemiddeld interval tussen de bronchiale sleeve resectie en de diagnose van 
de tweede primaire longtumor was 53,8 maanden (interval 6-197). Alle 
tweede primaire longtumoren traden op aan de contralaterale zijde. 
Histologisch onderzoek toonde spinocellulair carcinoom bij 5 patiënten, 
adenocarcinoom bij 2, adenosquameus carcinoom bij 1, kleincellig 
carcinoom bij 2 en bij 1 patiënt kon geen definitieve histologie verkregen 
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worden. Histologie was verschillend van de primaire tumor in S gevallen. 
Zeven patiënten (64%) werden geopereerd : 5 lobectomies en 2 
segmentectomies. Bij één patiënt werd de tumor als inoperabel beschouwd. 
De twee patiënten met een kleincellig carcinoom werden behandeld met 
chemotherapie en radiotherapie werd gegeven aan een patiënt met 
botmetastasen. 
Follow-up was volledig voor de 11 patiënten. De gegevens werden 
berekend vanaf het ogenblik van diagnose van de tweede primaire longtumor. 
Eén patiënt overleed postoperatief t.g.v. een myocardinfarct. Tijdens de 
follow-up periode stierven 8 andere patiënten : 5 t.g.v. een lokaal recidief 
of metastasen, 2 t.g.v. cardiale insufficiëntie en 1 t.g.v. van een geperforeerd 
maagulcus. 
De aktuariële overleving na 1 en4 jaar was 41 en 30%. Voor de geopereerde 
patiënten bedroeg de overleving na 1 en 4 jaar 57 en 43%. Na 5 jaar waren 
er echter geen patiënten meer in leven. 
Een restpneumonectomie werd uitgevoerd bij 19 patiënten (13,1%). 
Indicaties waren een goedaardige bronchusstenose bij 10 patiënten, een 
positief resectievlak bij 3, een lokaal recidief bij S en een dehiscentie van 
de anastomose bij 1 patiënt. De gemiddelde leeftijd bij de sleeve resectie 
bedroeg 59,3 jaar. 
Bij histologisch onderzoek werd een spinocellulair carcinoom aangetroffen 
bij 18 patiënten en een carcinoid tumor bij 1. Het gemiddeld interval tussen 
de sleeve resectie en restpneumonectomie was 5,7 maanden (interval 3-16) 
voor de patiënten met een bronchusstenose en 6,6 maanden voor de overige 
(interval 1-17). 
Drie patiënten overleden postoperatief (15,8%). 
De gemiddelde follow-up bedroeg 53,2 maanden. De aktuariële overleving 
na 5 en 10 jaar na de restpneumonectomie was 54 en 41 % voor de patiënten 
met een bronchusstenose en 52 en 52% respectievelijk voor de overige. 
Conclusies : 
1. Voor een nauwkeurige preoperatieve stagering van het mediastinum 
bij een bronchuscarcinoom is een routine cervicale mediastinoscopie 
noodzakelijk. 
2. Bij centraal gelegen tumoren aan de linker zijde moet tijdens een 
antérieure mediastinotomie het pericard geopend worden om te 
bepalen of een intrapericardiale pneumonectomie mogelijk is. 
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3. Na een bronchiale sleeve resectie is de overleving het best voor 
carcinoid tumoren en spinocellulaire carcinomen zonder metastatische 
lymfeklieren. Voor wat de kategorieën N1 en N2 betreft is de overleving 
significant lager zonder overlevenden na 10 jaar en geen significant 
verschil tussen klierstadium N1 en N2. 
4. Wanneer we metastasen op afstand als doodsoorzaak na een sleeve 
resectie in beschouwing nemen, is er een significant verschil tussen 
kategorie N0 enerzijds en de gecombineerde kategorieën N1 en N2 
anderzijds, maar is er geen verschil voor wat betreft lokaal recidief als 
doodsoorzaak. 
5. Voor centraal gelegen bronchiale carcinoid tumoren is een sleeve 
resectie, soms in combinatie met lasertherapie, te verkiezen boven 
een meer uitgebreide resectie van longweefsel. 
6. Sleeve resectie is een waardevolle methode om functioneel longweefsel 
te sparen. Dit houdt de mogelijkheid van een tweede resectie open bij 
patiënten die een tweede primaire longtumor ontwikkelen. 
7. Ondanks het feit dat de operatieve mortaliteit van een restpneumo-
nectomie na een sleeve resectie vrij hoog ligt, is de overleving op 
lange termijn goed, welke ook de indicatie was voor de ingreep. 
11.3. Résumé et conclusions 
Résection-anastomose des bronches : résultats à long terme. 
Les cancers bronchiques restent une cause importante de mortalité dans 
notre société. Quand une résection paraît possible, l'exérèse chirurgicale 
est le traitement de choix. 
Un staging précis préopératoire par rapport à la classification TNM est très 
important pour instaurer le meilleur traitement et pour mieux évaluer le 
pronostic ultérieur. 
La valeur de la médiastinoscopie dans le staging préopératoire des cancers 
bronchiques est fort controversée. Pour déterminer plus exactement son 
rôle les résultats de la médiastinoscopie et de la tomodensitométrie chez 85 
patients ont été comparés aux données de la thoracotomie. Une 
médiastinoscopie a été effectuée chez 48 patients pour lesquels la 
tomodensitométrie montrait des ganglions d'un diamètre d'un centimètre 
ou plus. Dans ce groupe, seulement 21 patients (44%) présentaient des 
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ganglions envahis. 
Parmi les patients restants, 22 ont été opérés avec deux résultats faux 
négatifs (9%). La médiastinoscopie avait une sensitivité de 91% et une 
spécificité de 100%. La valeur prédictive positive de la tomodensitométne 
était de seulement 54%. 
Trente-sept patients ayant un résultat négatif à la tomodensitométne ont 
subi une thoracotomie. Dans ce groupe, 11 patients (30%) avaient des 
ganglions médiastinaux positifs. La valeur prédictive négative de la 
tomodensitométrie était de 70%. En rassemblant les résultats des deux 
groupes de patients, la sensitivité et la spécificité de la tomodensitométrie 
étaient 68 et 57% respectivement avec une exactitude de 61%. 
A l'Hôpital Antonius à Nieuwegein, une médiastinoscopie cervicale de 
routine est effectuée pour obtenir un staging exact du médiastin. A 
l'Hôpital Universitaire d'Anvers une attitude plus sélective est préférée. 
Une médiastinoscopie cervicale est effectuée chez chaque patient présentant 
une tumeur centrale. Dans le cas d'un cancer épidermoïde périphérique ou 
d'un nodule mesurant moins de 3 centimètres et pour lequel il n'y a pas de 
diagnostic histologique une médiastinoscopie n'est pas effectuée si la 
tomodensitométrie montre des ganglions d'un diamètre inférieur à un 
centimètre. 
Pour les cancers centraux du lobe supérieur gauche, en plus d'une 
médiastinoscopie cervicale, une médiastinoscopie ou médiastinotomie 
antérieure gauche est recommandée pour dépister les métastases dans les 
ganglions péri- et subaortiques. 
Pour juger de l'opérabilité des cancers centraux gauches, il est possible 
d'ouvrir le péricarde pendant une médiastinotomie antérieure pour 
déterminer ainsi si une pneumonectomie intrapéricardiale est possible. 
Pendant une période de 3 ans cette procédure a été effectuée chez 11 
patients. Chez 3 (27,3%) une extension intrapéricardiale importante rendait 
une résection complète impossible. Une extension à l'intérieur du péricarde 
sans invasion complète des vaisseaux pulmonaires était présente chez 2 
patients (18,2%); ceux-ci ont subi par la suite une pneumonectomie 
intrapéricardiale. Chez 6 patients (54,5%) il n'y avait pas d'extension 
tumorale dans le péricarde. 
Π n'y a pas eu de mortalité périopératoire. 
Suite à un pneumothorax postopératoire le drainage de la cavité pleurale a 
dû être repris chez un patient. 
Au total, 4 patients (36,4%) ont subi une pneumonectomie intrapéricardiale, 
6 (54,5%) ont été traités par radiothérapie et un (9,1 %) par chimiothérapie. 
Ainsi, cette procédure permet de dépister l'invasion tumorale de la cavité 
péricardiale et d'éviter les thoracotomies vouées à l'échec. 
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Dans cette thèse, les résultats à court et long terme des résections-
anastomoses bronchiques effectuées pour des tumeurs bronchiques à 
l'Hôpital Antonius ont été étudiés. Celles-ci comprennent les lobectomies 
avec résection-anastomose bronchique et les résections-anastomose d'une 
bronche souche, dans lesquelles une partie cylindrique a été enlevée suivi 
d'une anastomose termino-terminale. 
Dans la période 1960-1989,145 patients, soit 132 hommes et 13 femmes, 
dont l'âge moyen était de 60,3 ans, ont subi ime résection-anastomose des 
bronches. 
Les cancers épidermoïdes formaient l'indication dans la majorité des cas 
(116 patients, 80,0%), suivis des tumeurs carcinoïdes typiques chez 13 
patients (9,0%). La classification, staging, postopératoire montra 61 patients 
(42,1%) au stade 1,47 (32,4%) au stade Π, 33 (22,8%) au stade ΙΠΑ et 4 
(2,7%) au stade ΠΙΒ. La mortalité périopératoire était de 4,8%, soit 7 décès. 
Les complications postopératoires immédiates étaient surtout respiratoires: 
drainage prolongé d'air, atélectasie et insuffisance respiratoire. 
Un suivi complet a été possible chez tous les patients à l'exception d'un 
seul qui a été perdu de vue 4 ans après l'intervention. 
Une sténose bronchique bénigne s'est développée chez 13 patients (8,9%). 
Chez 10 de ces patients une pneumonectomie résiduelle a été effectuée, les 
3 autres ont eu une dilatation bronchoscopique. 
Une récidive locale a été observée chez 26 patients (17,9%). Cinq ont subi 
une pneumonectomie résiduelle, 19 dont 10 avaient également des 
métastases à distance sont morts de leur récidive locale ou de métastases, 
et 2 patients sont en vie avec une récidive locale. 
La survie actuarielle pour la série entière était de 49% à 5 ans, 37% à 10 ans 
et 18% à 15 ans. 
En considérant les 112 patients présentant des tumeurs épidermoïdes au 
stadeT2 et T3, la survie à 5 et 10 ans pour la catégorie N0 (52 patients) était 
de 59% et 47%, pour la catégorie N1 (51 patients), de 21% et 0% et pour 
la catégorie N2 (9 patients), de 44% et 0%, respectivement. In n'y avait pas 
de différence significative concernant la survie entre la catégorie N1 et N2. 
En examinant la cause de mortalité par rapport à l'atteinte ganglionnaire, 
il n'y avait pas de différence significative en ce qui concerne la récidive 
locale entre la catégorie N0 d'une part et les catégories N1 et N2 combinées 
d'autre part. Considérant la mortalité causée par les métastases à distance, 
la différence devenait cependant significative. 
Treize patients ont subi une résection-anastomose bronchique pour une 
tumeur carcinoïde des bronches centrales. Les opérations effectuées étaient 
7 lobectomies supérieures droites avec résection-anastomose bronchique, 
1 lobectomie inférieure gauche avec résection-anastomose bronchique, 2 
136 
résections-anastomoses de la bronche souche droite et 3 de la bronche 
souche gauche. Cinq patients ont été traités au laser avant Γ intervention (à 
partir de 1986). Une tumeur carcinoïde typique fut mise en évidence à 
l'examen histologique dans tous les cas. La classification, staging, 
postopératoire était T2N0M0 (stade I) chez 7 patients et T3N0M0 (stade 
ША) chez 6 patients. Π n'y a pas eu de mortalité périopératoire. Pendant 
le suivi d'une durée moyenne de 74,6 mois il n'y a pas eu de décès. Chez 
12 patients on a observé un bon résultat sans signe de récidive locale ou de 
sténose bronchique. Un patient a subi une pneumonectomie complémentaire 
16 mois après l'intervention à cause d'une sténose de l'anastomose sans 
récidive évidente. 
En cas de tumeurs carcinoïdes bronchiques centrales les résections-
anastomoses sont à préférer aux résections plus larges. En général, il s ' agit 
de patients jeunes où l'économie de tissu pulmonaire est très importante 
pour l'avenir. 
Pendant le suivi des 145 patients qui ont subi une résection-anastomose des 
bronches, 11 patients (7,6%), dont 10 hommes (90,9%) ont développé un 
deuxième cancer primaire pulmonaire métachronique. 
L'âge moyen à la résection-anastomose bronchique était de 61,2± 11,6 ans. 
L'intervalle moyen entre la résection-anastomose bronchique et le diagnostic 
du deuxième cancer primaire était de 53,8 mois (intervalle 6-197). Tous les 
deuxièmes cancers primaires étaient localisés du côté controlatéral de la 
première tumeur. L'examen histologique montra un cancer épidermoïde 
chez 5 patients, un adénocarcinome chez 2, une tumeur épidermoïde et un 
adénocarcinome combinés chez 1, un carcinome à petites cellules chez 2, 
et chez 1 patient un diagnostic histologique n'a pu être établi avec certitude. 
Une histologie différente de la première tumeur était présente chez 5 
patients. 
Sept patients (64%) ont été opérés : 5 lobectomies et 2 segmentectomies. 
Chez un patient la tumeur était considérée comme inopérable. Les 2 
patients présentant un carcinome à petites cellules ont reçu de la 
chimiothérapie et un patient présentant des métastases osseuses a bénéficié 
de la radiothérapie. Le suivi était complet pour les 11 patients. Les données 
ont été calculées à partir de la détection du deuxième cancer primaire. 
Un patient a succombé après l'opération à un infarctus du myocarde. 
Pendant le suivi 8 autres patients sont décédés : 5 d'une récidive locale ou 
de métastases, 2 d'une insuffisance cardiaque et 1 d'une perforation d'un 
ulcère gastrique. La survie actuarielle à 1 et 4 ans était de 41 et 30%. Pour 
les patients opérés la survie à 1 et 4 ans était de 57% et 43%. Il n'y avait pas 
de survivants à 5 ans. 
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Une pneumonectomie complémentaire a été nécessaire chez 19 patients 
(13,1%). Les indications étaient une sténose bronchique bénigne chez 10 
patients, une atteinte de la tranche de section bronchique chez 3, une 
récidive locale chez 5, et une dehiscence de l'anastomose chez 1 patient. 
L'âge moyen à la résection-anastomose bronchique était de 59,3 ans. 
L'examen histologique démontra un cancer épidermoïde chez 18 patients 
et une tumeur carcinoïde chez 1. L'intervalle moyen entre la résection-
anastomose bronchique et la pneumonectomie complémentaire était de 5,7 
mois (intervalle 3-16) chez les patients avec une sténose bronchique et 6,6 
mois chez les autres (intervalle 1-17). 
Il y a eu 3 décès postopératoires (15,8%). 
Le suivi moyen était de 53,2 mois. La survie actuarielle à 5 et 10 ans après 
la pneumonectomie complémentaire était de 54 et 41 % pour les patients 
avec une sténose bronchique et de 52 et 52%, respectivement pour les 
autres. 
Conclusions : 
1. Un staging précis préopératoire du médiastin en cas de cancer 
bronchique nécessite une médiastinoscopie cervicale de routine. 
2. En cas de tumeur centrale à gauche il est indispensable d'ouvrir le 
péricarde pendant une médiastinotomie antérieure pour déterminer si 
une pneumonectomie intrapéricardiale est encore possible. 
3. La survie après une résection-anastomose bronchique est meilleure 
pour les tumeurs carcinoïdes et épidermoïdes sans invasion 
ganglionnaire. Dans la catégorie N1 et N2 la survie est signifîcativement 
réduite, et même nulle à 10 ans. Il n'y a pas de différence significative 
entre la catégorie N1 et N2 de ce point de vue. 
4. Prenant en considération les métastases à distance comme cause de 
mortalité après une résection-anastomose bronchique, il y a une 
différence significative entre la catégorie N0 d'une part et les catégories 
N1 et N2 combinées d'autre part. Π n'y a pas de différence en ce qui 
concerne les récidives locales. 
5. Pour des tumeurs carcinoïdes centrales les résections-anastomoses 
bronchiques, parfois en combinaison avec le traitement au laser, sont 
à préférer à des exérèses comprenant plus de tissu pulmonaire. 
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6. La résection-anastomose bronchique est une méthode valable de 
préservation de tissu pulmonaire fonctionnel, permettant une deuxième 
résection chez les patients qui développent un deuxième cancer 
primaire du poumon. 
7. Même si la mortalité périopératoire d'une pneumonectomie 
complémentaire après une résection-anastomose des bronches est 
élevée, la survie à long terme est bonne, quelle que soit l'indication 
de l'intervention. 
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